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Background: Current frailty screening tools have not been validated for day-to-day use in acute 
care (Binder, 2015). Many recommended tools include subjective questions and take too much 
time to complete in a fast-paced clinical environment (Morley et al., 2013). It is for this reason 
that hand grip strength and gait speed have been chosen as tools to be evaluated for their 
feasibility and potential utility as single indicators of frailty for use in acute care. A useful 
indicator should add value to a clinical assessment, such as predicting key outcomes to identify 
those patients who need more intensive treatment. The predictive validity of frailty measures has 
been studied extensively in the literature in connection to many different health related 
outcomes.  However, their predictive validity in relation to length of hospital stay and quality of 
life during and post-discharge from acute care requires further investigation. The More-2-Eat 
study provides an ideal opportunity to address these knowledge gaps. 
Purpose: (1) To determine the feasibility of two frailty indicators (5m and HGS) for acute care 
patients, (2) to determine the predictive validity of these tools with respect to LOS, and (3) to 
determine if these frailty indicators predict quality of life during and post-discharge from acute 
care. 
Methods and findings: More-2-Eat was a multi-site participatory action research study with a 
before-after time series design.  The primary objective of the study was to implement and 
evaluate the Integrated Nutrition Pathway for Acute Care (INPAC) in Canadian hospitals. Each 
site was led by an interdisciplinary team, which offered coaching and improvement strategies 
towards implementing nutrition care best practices. The study population were all patients on the 
chosen medical unit for implementation of INPAC at the: Royal Alexandra Hospital (Edmonton, 




Health System, General Site (Niagara Falls, ON), and Ottawa Hospital (Ottawa, ON). There 
were two key aspects of data collection at the patient level; an 1) audit of nutrition care practices 
for all patients on the unit during monthly audit days, and 2) a detailed assessment of nutrition, 
frailty, disability, quality of life and food intake on a subset of patients recruited each month. 
This latter data collection was used for this study. There were 1250 detailed patient data 
collections over a 15-month period for analysis. Data included demographics, primary admission 
diagnosis, length of stay, nutritional risk (and diagnosis of malnutrition if relevant), an estimate 
of a single meal’s food intake, barriers to food intake, self-reported quality of life, self-reported 
disability, frailty indicators, patient reported perceptions on adequacy of food intake and 
nutritional health, and nutrition care provided in the hospital at the time of the data collection. 
All data were typically collected over one to three days for each patient. Items used in this thesis 
include: handgrip strength (HGS) (n=1146, mean=20.82 kg), five meter timed walk (5m) 
(n=535, median=6.79 sec), subjective global assessment (SGA), perceived functional status 
(Nagi scale), length of stay (LOS), quality of life (QOL), demographics, and reasons for non-
completion of assessments.  (1) Descriptive statistics revealed that HGS is a more feasible 
indicator of frailty than the 5m in acute care medical patients, as the completion rate was over 
90%; 5m walk could not be completed in more than 50% of patients. Further, HGS had high 
completion rates across all sites and for diverse populations (diagnoses, sex). HGS was 
associated with key patient characteristics such as nutritional status (t=4.13, p<0.0001) and 
perceived functional status (t=10.69, p<0.0001). (2) Multiple linear regression modeling revealed 
that the addition of HGS as an indicator of frailty significantly improved the predictive value for 
both male (X2=3.9, p<0.0001) and females (X2=2.0, p<0.05) for LOS, whereas 5m was not 




sensitivity and specificity. (3) Multiple linear regression modeling also revealed that the addition 
of HGS as an indicator of frailty significantly improved the predictive value of both the male 
(X2= 31.78, p<0.01) and female models (X2= 21.02, p<0.01) with respect to the physical 
component of QOL in hospital (PCS1) and post-discharge (PCS2) (X2=10.62, p<0.01; X2= 
10.75, p<0.01), whereas 5m added significant predictive value across sexes for the physical 
component of QOL in hospital (PCS1) (X2=9.42, p<0.01; X2=15.72, p<0.01), but not 30 days 
post-discharge (PCS2). 
Conclusion: Overall, HGS appears to be a more appropriate single indicator of frailty for 
consideration in acute care. This tool is feasible for diverse patients and results are associated 
with nutritional status and perceived functional disability, indicating that it is likely measuring 
frailty (as defined by Fried, 2001). HGS also appears to be relevant for predicting important 
outcomes and clinical decision-making. Lower HGS values were correlated with longer LOS and 
poorer physical QOL. HGS also provided additional predictive value for LOS and physical QOL 
in hospital and 30 days post-discharge when adjusting for other covariates that would be 
collected in a clinical setting, including nutritional status. Consideration for use of this tool in 
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Chapter 1: Introduction 
The following Master’s thesis consists of three separate main research questions, 
pertaining to frailty and health-related outcomes in acute care. Each main research question and 
sub-questions will be addressed in an individual draft manuscript; analyses are based on 
secondary data from the More-2-Eat study (M2E).  
More-2-Eat was a participatory action research study using a before-after time series 
design to study the implementation of improved nutrition care practices in five sites in Canada. 
The aim of this study was to “optimize nutrition care in hospitals, and thus performance of the 
healthcare system, by ensuring that malnutrition and poor food intake are prevented, detected 
and treated, hence promoting the recovery, function and quality of life of patients, with particular 
attention on the needs of frail elderly (>65)” (Keller, 2015, p. 8).   Primary outcomes of this 
study included “fidelity to the INPAC (Integrated Nutrition Pathway for Acute Care) 
components (e.g. % screening, monitoring); patient reported outcomes of barriers to food intake 
and their self-rating on importance of nutrition to their recovery; and change in staff knowledge, 
attitudes, and practices” (Keller, 2015, p.8).  Secondary outcomes were anticipated to occur if 
primary outcomes arose. Specifically, it was hypothesized that “patient length of stay, 30-day 
readmission, patient-reported food intake during hospitalization, frailty, and quality of life would 
all improve with full implementation of the INPAC” (Keller, 2015, p. 8).  
This research used data collected in M2E from all five sites.  There were approximately 
1250 detailed patient data collections over an 18-month period for analysis, which included key 
measures used in this thesis. Specifically, data incorporated in Chapters 4 through 6 of this thesis 
include: handgrip strength (kg), 5m walk (seconds), patient length of stay (LOS; days), and 




frailty indicators for acute care patients. It will then determine the predictive validity of these 
tools with respect to LOS, and finally will examine which if these frailty indicators predict 
quality of life during and post-discharge from acute care.  
This research will help to create a better understanding of how frailty can be identified in 
an acute care setting, and if these tools can be used to predict important health outcomes. One of 
the goals of this research is to gain a better understanding of the feasibility of potential frailty 
indicators to ultimately promote the use of the most appropriate tools in acute care. Another 
important goal of this research is to analyze and validate cut-points that can be used to make 
decisions with respect to improvement of important outcomes such as prolonged length of stay. 
Predictive cut-off points may help reduce length of stay for patients in acute care, by promoting 
earlier intervention as needed, and consequently, reduce costs to the Canadian health care 
system. This research will also contribute to a better understanding of factors influencing quality 
of life during and post-discharge from acute care. As health care shifts focus toward a more 
patient-centered philosophy of care, patient reported outcomes are becoming increasingly 
important for decision-making. Quality of life is a multi-dimensional outcome, which lends itself 
to a well-rounded understanding of physical, mental and social wellbeing (Fayers & Machin, 
2013). Appreciating factors that might predict this outcome will allow health care providers to 




Chapter 2: Background 
 The following review of the literature will begin by conceptualizing the notion of frailty, 
discuss how it is measured and identified and explore its prevalence and significance. This 
review will then focus on malnutrition, and its’ conceptual overlap with frailty. This will lead to 
a discussion on handgrip strength and the 5-meter walk as potential indicators for frailty their 
connection to malnutrition, and their possible use in acute care settings. Focus will then shift to 
length of hospital stay, and its prevalence and significance in a Canadian context and why it is a 
relevant outcome variable. This review will aim to address why length of hospital stay is an 
issue, and why frailty is an important consideration within that issue. Finally, quality of life will 
be discussed. This review will aim to conceptualize quality of life, describe how it is measured, 
why it is an important patient-reported outcome, and explore some of its current predictors in the 
acute care context.  
2.1 What is Frailty? 
 Conceptualizing frailty is of considerable interest in the research and practice 
communities, but consensus on what factors are necessary for defining frailty have appeared to 
be inconsistent for a long period of time (Conroy, 2009; Fried, Ferrucci, Darer, Williamson & 
Anderson, 2004; Fried et al., 2001; Rockwood & Mitnitski, 2007). Two main models for 
conceptualizing frailty have been consistently used in the literature: the phenotype model and the 
cumulative deficit model (Clegg, Young, Illiffe, Rikkert & Rockwood, 2013; Fried et al., 2001, 
Morley et al., 2013; Rockwood & Mitnitski, 2007). Fried established the phenotype model in 
2001, based on a review of prior research and clinical consensus. This model posits that frailty is 
characterized by the presence of three or more of the following features: shrinking (e.g. weight 




2001). Conversely, the cumulative deficit model defines frailty as an accumulation of deficits 
over time that reduces one’s capacity to resist stressors (Rockwood, 2007). Despite the 
conceptual differences, research has demonstrated that both models have significant statistical 
convergence, helping to create a more consistent construct of frailty (Clegg et al., 2013).  
More recently, work has been focused on coming to a consensus with regard to defining 
frailty, in an attempt to determine whether or not there is sufficient information available to 
promote screening for frailty by all physicians in all settings (Morley et al., 2013).  In 2012, a 
consensus meeting was held, with six international, European and US societies represented 
(Morley et al., 2013). The group of experts defined frailty as “A medical syndrome with multiple 
causes and contributors that is characterized by diminished strength, endurance, and reduced 
physiologic function that increases an individual's vulnerability for developing increased 
dependency and/or death” (Morley et al., 2013 p. 393). This group also made four consensus-
based statements and recommendations pertaining to frailty:  
1. Frailty is an important medical syndrome 
2. Simple screening tests are accessible to physicians to recognize frail persons and 
identify persons with physical frailty or at risk of frailty  
3. Physical frailty is a manageable condition 
4. All persons >70 years of age should be screened for frailty.  
(Morley et al., 2013, p. 393-395) 
Of particular interest from this consensus was the identification of simple screening tests that 
already exist and can be used by physicians to identify frailty. This will be further discussed in a 




to a consensus, recent reviews of relevant literature have shown that research on successful or 
healthy aging has failed to keep up with the focus on frailty (Friedman, Shah & Hall, 2015).   
It is currently estimated that over 1 million Canadians are frail (Hoover, Roterman, 
Sanmartin & Bernier, 2013). Prevalence rates for frailty range from 10-20% of community 
dwelling older adults (>65 years), with higher rates among women than men (Collard, Boter, 
Schoevers & Oude Voshaar, 2012; Song, Mitnitski & Rockwood, 2010). With the presence of a 
chronic disease such as cancer, rates of frailty increase significantly; for example, over 50% of 
older cancer patients are considered pre-frail or frail (Handforth et al., 2015). Although frailty is 
not unique to older adults, frailty rates increase substantially with age (Fried et al., 2001; Song et 
al., 2010; Collard et al., 2012).  Statistics Canada predicts that by the year 2036, nearly 1 in 4 
Canadians will be over the age of 65 (Statistics Canada, 2015). With a large proportion of the 
Canadian population at risk of being frail, screening and measuring frailty in a reliable manner is 
essential to identify this condition as early as possible to provide potentially useful treatments 
and services.  
2.2 Malnutrition and the overlap with Frailty 
According to the Canadian Malnutrition Task Force, malnutrition involves any nutritional 
imbalance, including a deficiency or an excess of energy, protein and other nutrients that leads to 
body composition change and functional impairment. However, in an acute care setting, 
malnutrition (referring specifically to undernutrition and inadequate intake of energy, protein and 
other nutrients) is of primary concern (Canadian Malnutrition Task Force, 2014).  Furthermore, 
roughly 45% of hospitalized patients who stay in hospital more than two days are malnourished 
(Allard et al., 2015). That being said, there is no universally accepted method or criteria to 




loss (Ferguson M, Capra S, Bauer J, Banks M, 1999), to complex laboratory and anthropometric 
assessments (Ingenbleek & Carpentier, 1985). The European Society of Clinical Nutrition and 
Metabolism (ESPEN) defined malnutrition as a body mass index (BMI) <18.5, or the 
combination of unintentional weight loss along with a reduced BMI or a low fat free mass index 
(FFMI) (Cederholm et al., 2015). Conversely, Jensen and colleagues defined malnutrition as an 
overall “decline in lean body mass, with the potential for functional impairment” (as cited in 
White et al., 2012, p. 730). This definition contributed to the Academy of Nutrition and Dietetics 
and the American Society for Parenteral and Enteral Nutrition’s (A.S.P.E.N) recommendation 
that a standardized set of diagnostic criteria be used to recognize and record malnutrition in 
clinical practice (White et al., 2012). This group recommended that at least 2 of the following 6 
criteria need to be present in order to identify malnutrition: insufficient energy intake, weight 
loss, loss of muscle mass, loss of subcutaneous fat, localized or generalized fluid accumulation, 
and diminished functional status (White et al., 2012). The frailty indicators used in this study 
(handgrip strength and gait speed) are good indicators of the functional status aspect of this six-
domain construct of malnutrition (Clegg et al., 2013; Chung et al., 2014; Jeejeebhoy, 2012; 
Savva et al., 2012; Studenski et al., 2003). A tool commonly used to assess malnutrition is the 
Subjective Global Assessment (SGA) (Detsky et al., 1987). This standardized tool meets the 
aforementioned criteria, and has been validated for use in acute care (Fontes, D., de Vasconcelos 
Generoso, S., & Correia, M. I. T. D., 2014). However, this tool requires clinical judgment and 
takes sufficient time to complete by a trained dietitian or other health professional.  
The overlap in constructs of frailty and malnutrition are important to understand, 
especially when considering the phenotype concept of frailty, which includes weight loss and 




highlighted the overlap between phenotypes of malnutrition and frailty. It was concluded that 
loss of body tissues, resulting in wasting is a common phenotype for several conditions, 
including frailty and malnutrition (Jeejeebhoy, 2012). A recent study on rural elderly Lebanese 
investigated the independent relationship between the construct of frailty and malnutrition 
(Boulos Salameh & Barberger-Gateau, 2016). Frailty was assessed using the Study of 
Osteoporotic Fractures (SOF) measure, which includes: involuntary weight loss of more than 5 
kg during the past year, inability to rise from a chair five times without using arms and reduced 
energy level for at least 3 days during the past week (Boulos et al., 2016). Additionally, 
malnutrition was assessed using the Mini Nutritional Assessment (MNA), while adjusting for 
age and other covariates (Boulos et al., 2016). The results of this study revealed that malnutrition 
and risk of malnutrition were related to an almost four-fold increase in risk of frailty (Boulos et 
al., 2016). However, it should be noted that risk of malnutrition and malnutrition diagnoses are 
measured differently and risk tools are distinctive from diagnostic tools. Nonetheless, Boulos et 
al. (2016) determined that there is a significant association between malnutrition and frailty and 
that these constructs share common socio-demographic, physical and cognitive links. In 2002, 
Bales and Ritchie termed the concept of ‘nutritional frailty’, which refers to “rapid, unintentional 
loss of body weight and accompanying disability that often signals the beginning of a terminal 
decline in an elderly individual” (p. 310). This conceptual overlap is critical to recognize when 
considering identifying frailty in a hospital setting, as assessment tools for both frailty and 
malnutrition currently rely on lengthy, subjective tools, and feature similar diagnostic symptoms.   
2.3 Measuring and Screening for Frailty  
 Methods for measuring and screening for frailty are also inconsistent and diverse within 




is required to effectively target appropriate care.  More recently, consensus regarding defining 
and screening for frailty has emerged with recommendations coming from an international body 
(Morley et al., 2013). One of the recommendations was that simple screening tests for frailty 
exist and should be used by physicians for older adults (Morley et al., 2013). The screening tests 
suggested by these experts included: FRAIL (Abellan et al., 2008), the Cardiovascular Health 
Study Frailty Screening Measure (Fried et al., 2001), the Clinical Frailty Scale (Rockwood et al., 
2005), and the Gérontopôle Frailty Screening Tool (Subra, Gillette-Guyonnet, Cesari, Oustric & 
Vellas, 2012) (Morley et al., 2013). Although these tests have been recommended for physician 
use, three of the four aforementioned tools are subjective measures. The fourth tool, the 
Cardiovascular Health Study Frailty Screening Measure (Fried et al., 2001), involves a battery of 
objective measures, including gait speed and grip strength. That being said, in a clinical setting, 
it is essential that screening tools be simple, objective, and preferably single measures or 
indicators to ensure efficiency.  
Cesari et al., (2016) recently noted that “the most appropriate frailty instrument should 
rely on the purpose of the evaluation, the outcome for which the definition was originally 
validated, the validity of the tool, the studied population and the setting in which the assessment 
will be conducted” (p.191). Cesari et al. (2016) suggested that objective; physical performance 
measures, which are more focused on the functioning of the individual, are preferable to 
subjective evaluations for measuring frailty, especially when conducting assessments in a clinical 
or hospital setting. A recent study was conducted in Taiwan to evaluate the predictive abilities of 
single items and their combinations in the instrumental activities of daily living and Nagi scales 
to predict care needs of older adults (Hsu, Chen & Wang, 2017). These results highlighted 




predicting care needs of older adults (Hsu et al., 2017). These single indicators are also 
consistent with Fried’s phenotype model of frailty  (Fried, 2001). In a Canadian context, the 
interRAI Assessment Urgency Algorithm (AUA) was implemented in primary care settings and 
an emergency department to trial a standardized approach to risk assessment (Elliott, Gregg, Reg 
& Stolee, 2016). However, this assessment needs to be validated against a criterion for frailty 
and its’ association with other relevant constructs such as nutritional status requires further 
research to consider its’ use for fast paced acute care.  
 Although specific frailty screening tools exist, none have demonstrated validity for acute 
care settings (Binder, 2015). Therefore, the use of these tools in clinical settings needs further 
study (Binder, 2015). Gait speed and handgrip strength have both been investigated in the 
literature as appropriate indicators of frailty (Clegg et al., 2013; Chung et al., 2014; Jeejeebhoy, 
2012; Savva et al., 2012; Studenski et al., 2003). Additionally, studies have confirmed that 
decreased muscle strength (specifically grip strength) is a good indicator of frailty (Bohannon 
n.d, Jeejeebhoy, 2012; Morley et al., 2013; Roberts et al., 2011,). Although the use of these 
objective measures has been discussed in the literature (Morley et al., 2013; Studenski et al., 
2003), a comparison in terms of the feasibility of these tools as single indicators of frailty in an 
acute care setting has yet to be established.   
2.3.1 Gait Speed as an Indicator of Frailty 
Slow gait speed has been reported to successfully characterize older adults who have 
experienced adverse outcomes, such as frailty (Clegg et al., 2013; Jeejeebhoy, 2012; Morley et 
al., 2013). Gait speed has also been shown to be associated with or predict a variety of health 
related outcomes, including: physical performance and incidence of falls (Scott et al., 2014), 




cardiovascular patients (Chiaranda et al., 2013), dyspnoea and health related quality of life 
(HRQOL) among COPD patients (Kon et al., 2013). Specifically, recent literature has provided a 
cut-point of > 6 seconds (determined by receiver-operator characteristic curves) as an indicator 
of frailty during the timed 5-metre walk test (Afilalo, 2010; Wilson, Kostsuca & Boura, 2015). 
Other literature suggests that a usual gait speed of <1m/s identifies a person at high risk of health 
related outcomes (Cesari et al., 2005). Decreased gait speed or ‘slowness’ is one of the 
components of the phenotype concept of frailty, as defined by Fried (2001), making it potentially 
a useful single indicator of frailty. Although cut-points have been suggested, they require 
evaluation in terms of sensitivity and specificity for use in acute care patients.  
2.3.2 Handgrip strength as an indicator of frailty and malnutrition  
Another important component of Fried’s phenotype model is weakness, or decreased 
strength, highlighting the importance of considering handgrip strength (HGS) as a useful tool to 
indicate frailty (Fried, 2001). Kim, Higgins, Canaday, Burant & Hornick (2014) conducted 
assessments (Fried and Gill Frailty Instruments) on 162 male American veterans. Their results 
supported the contention that grip strength might be an important indicator of increasing frailty 
(Kim et al., 2014). Sydall, Cooper, Martin, Briggs and Sayer (2003) went as far as suggesting 
that HGS could be a single indicator of frailty. However, HGS has also become a popular tool to 
identify malnutrition (Norman et al., 2011).  A systematic review was conducted, highlighting 
decreased muscle function in relation to nutritional deprivation, and found that HGS is being 
used often as an indicator for nutritional status (Norman et al., 2011). Flood et al. (2014) 
investigated whether or not HGS could be used as a single marker of nutritional status among 
hospital patients. Results of this study confirmed that PG-SGA scores (a valid measure of 




HGS is potentially an appropriate single marker of nutritional status (Flood et al., 2014). 
However, a recent article provides a different perspective. Jeejeebhoy et al. (2015) identified that 
SGA was more useful than anthropometry and serum albumin for predicting length of stay and 
readmission, and thus is the most robust measure for assessing nutritional status that should be 
used in acute care to diagnose malnutrition. HGS added additional predictive value, implying 
that HGS is potentially measuring something in addition to SGA (Jeejeebhoy et al., 2015), and 
thus beyond malnutrition.   
 Handgrip strength values have been used in the past to determine or predict a number of 
different health related outcomes (Rijk, Roos, Deckx, van den Akker & Buntinx, 2016). 
Furthermore, handgrip strength cut-off points have been established in the current literature to 
determine and predict outcomes including: cognition, mortality, functional status and 
hospitalization (Rijk et al., 2016, Stessman et al., 2017). However, comparison to a key outcome 
in acute care, specifically length of stay, has been rare (Jeejeebhoy et al., 2015). Predictive 
validity relating to length of stay and use of sensitivity and specificity to determine potential cut-
off points has yet to be established in the literature for this group.  
2.4 Length of Stay  
 Length of hospital stay is defined as the day of admission to hospital to the moment of 
discharge or death (Isabel, Correia & Waitzberg, 2003).  According to the Canadian Institute of 
Health Information (CIHI), in 2013-2014 there were more than 2.9 million acute care 
hospitalizations in Canada, and after adjusting for age (which is associated with length of stay), 
the average length of hospital stay (LOS) was 7.0 days (CIHI, 2014). Currently, 10% of the acute 
care population is experiencing LOS longer than 30 days (CIHI, 2015). The most common 




days (CIHI, 2014). However, LOS increases significantly for the next most common reasons for 
hospitalization (respiratory diseases and heart attacks) accounting for 7.7 days and 5.1 days 
respectively (CIHI, 2014). With regard to surgical procedures, after cesarean sections, the most 
common reasons for hospitalization include knee replacements (4.3 days) and fractures (9.3 
days) (CIHI, 2014). However, research indicates that well-nourished patients have significantly 
decreased LOS as compared to malnourished patients (Isabel et al., 2003; Allard et al., 2015). 
LOS is also an important indicator of patient recovery. Shorter LOS benefits the patient in terms 
of decreasing their risk of deteriorating in terms of their physical condition. These trends 
highlight the need for efforts to continue to reduce length of stay, and the importance of 
considering nutritional status, and possibly, frailty in doing so.  
In the 2012-2013 fiscal year, acute inpatient hospitalizations in Canada cost 24.4 billion 
dollars (CIHI, 2014). Of that cost, respiratory diseases along with hip and knee replacements 
incurred the highest costs (CIHI, 2014). It is also important to understand which users are 
incurring the bulk of these costs to attempt to reduce them. According to CIHI (2015), typical 
high users include: seniors, those with chronic conditions or mental health conditions, those 
receiving palliative care, and those with socio-economic factors such as poverty. Another 
important consideration impacting LOS is malnutrition.  Allard et al. (2015) determined that 
HGS at admission, receiving nutrition support, and food intake ≤50% were all independently and 
significantly associated with length of stay. In addition, in 2012-2013, seniors (who are more 
likely to experience frailty and malnutrition) (Collard et al., 2012; Fried et al., 2001; Song et al., 
2010) accounted for 78% of the three most expensive types of hospital stays (CIHI, 2014).  
Canadian estimates suggest that malnourished patients cost on average $2000 more than a well-




malnutrition occurs in approximately 45% of all medical and surgical patients who stay more 
than 2 days (Allard, 2015; Curtis et al., 2016). 
Many components of health have been associated with LOS. For example, a multicenter 
observational study on predictors of LOS among older adults admitted to acute wards concluded 
that excessive polypharmacy was the strongest predictor of increased LOS among ER and 
elective surgery admissions (Vetrano et al., 2014). Cotts et al. (2014) noted that pre and 
perioperative factors were among significant predictors of LOS after implantation of a left 
ventricular assist device, while Suter-Widmer et al. (2012) identified that older age, respiratory 
rate, residing in a nursing home, and severity of disease state were important predictors of LOS. 
Many of these factors may result in or be correlated with the frailty status of patients.  
Frailty is a multi-faceted syndrome that consists of several different characteristics that 
could be associated with LOS. For example, Pichard et al. (2004) found that a low fat-free body 
mass index (e.g. shrinkage as per the phenotype definition) was a predictor of length of hospital 
stay, even when adjusting for age. Allard et al. (2015) discovered that HGS at admission to 
hospital was significantly associated with LOS, however this was not the focus of this study, but 
rather malnutrition. Strength and weight loss are important components of frailty based on 
Fried’s phenotype model (Fried et al., 2001), suggesting that some associations between 
components of frailty, malnutrition and length of stay exist.  
Peel, Navanathan & Hubbard (2014) investigated the predictive validity of gait speed 
relating to length of stay in post-acute transitional care for older adults white adjusting for age 
and sex. Peel et al. (2014) determined that gait speed at admission was significantly and 




gait speed and length of stay is plausible. However, this was a relatively small sample (n=351) 
and was conducted in transitional care, rather than acute care.  
One study specifically addressed the independent associations between HGS and LOS. 
Kerr et al. (2006) conducted a small clinical study with men and women who were on average 
83.7 years of age and found associations between HGS and LOS independent of sex; as well a 
higher admission grip strength was found to be associated with increased likelihood of an earlier 
discharge. However, no cut-off points were determined or tested in this small data set. 
Additionally, the demographic of the sample does not allow for associations to be assumed for 
all adult age groups, as this select group was elderly. The small data set and limited 
generalizability of this study warrants associations to be further explored between HGS and LOS 
in a larger sample, representative of a Canadian population, and adjusting for other covariates.   
This overview indicates that LOS is an important health related outcome, and that a 
significant gap needs to be addressed. HGS and gait speed need to be evaluated in terms of their 
association with LOS to determine their usefulness as potential tools to identify frailty, and 
therefore mediate precursors for increased LOS in acute care.  
2.5 Quality of Life  
Much like frailty, a consensus on how to objectively define the concept of quality of life 
(QOL) has not been established (Fayers & Machin, 2013). However, there are facets of the 
definition that have growing consensus. The first is that QOL is subjective (Boissel & Chiflet 
1992; Calman, 1987; Gerin, Dazord, Patrick & Erickson, 1993; Theofilou, 2013). Another 
agreed upon aspect of QOL is that it is multidimensional (Calman, 1987; O’Boyle, 1992; 
Schipper, 1990; Theofilou 2013); most instruments that assess this construct include physical, 




of the earliest multidimensional definitions of QOL was provided by the World Health 
Organization. This definition stated that health was “a state of complete physical, mental and 
social well-being, and not merely the absence of disease” (WHO, 1997 page 1).  Although 
quality of life takes on different meanings based on the area or discipline in which it is applied, 
definitions often emphasize components of happiness and satisfaction with life (Fayers & 
Machin, 2013; Theofilou, 2013). Health contributes significantly to quality of life, and its’ 
impact on QOL is referred to as health related quality of life (HRQOL) (Cunningham & Hunt, 
2015). HRQOL includes various domains, including physical status, psychological wellbeing, 
social interaction, economic and religious/spiritual status (Bennett, Torrance & Spilker 1996). 
Researchers are beginning to consider patient reported health related outcomes as descriptors of 
QOL, including pain, fatigue, depression and physical symptoms (Fayers & Machin, 2013).  
Only recently did the United States Food and Drug Administration begin to formally 
introduce patient reported outcomes into their surveillance (Food, 2013). The overarching reason 
for this change in practice is that these outcomes express information described by the patient 
that has not been filtered by a clinician or observer (Food, 2013). With the increased focus on 
patient-centered health care, patient reported outcomes such as QOL are becoming paramount 
(Deshpande, Rajan, Sudeepthi & Abdul Nazir, 2011). According to CIHI (2016), patient reported 
outcomes are valuable and essential tools to realizing health system goals. Deshpande et al. 
(2011) explained that in a disease like cancer, for example, determining a patient reported 
outcome such as QOL is extremely important due to the burden of symptoms, economic loss, 
challenges with home management and lack of emotional well-being. Knowing what is relevant 




symptoms influence these outcomes is important and can and should influence treatment 
decisions.  
 Agreement on the relevance of patient reported outcomes has further highlighted the 
importance of using QOL as an outcome measure in health care research (Richards, 1994). 
However, the issue of which tool to use is debatable. There are multiple measures of QOL, often 
developed for specific patient subgroups. Examples of disease-specific quality of life measures 
include: the Lehman QOL interview for mental health patients (Siu et al., 2015), the Parkinson’s 
Disease Questionnaire (PDQ-39) (Kegelmeyer et al., 2015), and the Quality of Life in Autism 
Questionnaire (QoLA) (Eapen, Crncec, Walter & Tay, 2014). In a general population of older 
adults the SF-36 general health survey has been used to measure HRQOL (LaMacciha et al., 
2014).  
 The M2E study used the SF-12 general health survey (Ware, J. E., Kosinski, M., Turner-
Bowker, D. M., & Gandek, B., 1995) designed specifically for acute care to measure QOL. This 
questionnaire focuses on both physical and emotional wellbeing and is relatively concise. A 
recent review suggested, “the SF-12 be used for screening populations for QOL as it received 
positive ratings for criterion validity, construct validity, reproducibility, and interpretability. 
Moreover, it is a relatively short questionnaire, which makes it suitable for all patients” 
(Hamoen, De Rooij, Witjes, Barentsz & Rovers, 2015 p. 25). However, the succinctness of this 
questionnaire is also one of its limitations. As such, SF-12 does not give insight into all 
dimensions of QOL and it focuses solely on physical and mental wellbeing.  
 Numerous researchers have attempted to determine predictors of QOL in a health 
care/acute care context. Many of the existing predictors of QOL are physical in nature, including 




impairment (Beck, Joseph, Belisle & Pilote, 2001; Engel et al., 2003; Paul et al., 2005; Terrell et 
al., 2004; Yamout et al., 2013).  Research has also identified many psychological and social 
factors impacting QOL, including: patient/physician communication, depressive symptoms, and 
socioeconomic status, (Beck et al., 2001; Engel et al., 2003; Grady, Jalowiec, & White-Williams, 
1999; Paul et al., 2005; Tripp, Nickel, Landis, Wang & Knauss, 2004). A study conducted by 
Luger et al., (2016) revealed that there was a significant association between nutritional status 
and QOL in pre-frail community dwelling older adults. Current literature clearly demonstrates 
that predictors of QOL are numerous and vary based on health status or condition. However, 
current research has yet to explore frailty measures specifically as potential predictors of QOL 
during and post-discharge from acute care.  
2.6 Summary 
Based on this brief review of relevant literature, understanding what is associated with 
the construct of frailty in acute care context, how it can feasibly be identified in this setting and 
how frailty is implicated in LOS and QOL needs to be established. LOS is an important health 
outcome and marker of quality of care. Shorter LOS will improve patient flow, patient recovery 
and health care costs.  Thus, identifying individuals who may have extended LOS using a simple 
indicator of frailty in addition to usual nutrition screening/assessment may support earlier 
treatment and thus potentially, earlier discharge. The construct of QOL and how it is measured 
was discussed, as well as its importance as a patient-reported outcome. Current predictors of 
QOL for acute care patients are limited and specifically single measures of frailty need to be 
investigated as potential predictors.  This research will aim to strengthen the literature in this 







Figure 1: Summary of Background Information.  
Frailty and malnutrition have specific defining criteria, but both encompass the notion of 
reduced functional capacity- hence the need for functional measures to add to a nutrition/frailty 
assessment toolkit. The proposed single indicators to be added to this toolkit are HGS and 5m. 







Chapter 3: Research Questions and Hypotheses 
 Current frailty screening tools have not been validated for day-to-day use in acute care 
(Binder, 2015). Many recommended tools include subjective questions and take too much time 
to complete in a fast-paced clinical environment (Morley et al., 2013). It is for this reason that 
grip strength and gait speed have been chosen as tools to be evaluated for their feasibility and 
utility as single indicators of frailty for use in acute care. A useful indicator should add value to a 
clinical assessment, such as predicting key outcomes to identify those patients who need more 
intensive treatment. The predictive validity of frailty measures has been studied extensively in 
the literature in connection to many different health related outcomes.  However, their predictive 
validity in relation to length of hospital stay and quality of life during and post-discharge from 
acute care requires further investigation. Once feasibility has been determined, the predictive 
validity of these measures in relation to length of stay and quality of life should then be studied. 
The More-2-Eat study provides an ideal opportunity to address these knowledge gaps. These 
research questions will be addressed in the following three manuscripts:  
Feasibility of Frailty Indicators in Acute Care  
1. Is there a difference in completion rate between the handgrip strength (HGS) measure 
and the five meter timed walk (5m) measure used for detecting frailty in an acute care 
setting? 
 
Ho: There is no difference in the proportion of M2E acute care patients who complete 
handgrip strength and 5m walk. 
Ha: There is a difference in the proportion of M2E acute care patients who complete 
handgrip strength and 5m walk. 
 
2. What are the patient characteristics (e.g. age, sex, perceived disability, nutritional status, 
LOS, admission category, site) associated with the completion or non-completion of each 
frailty measure (HGS and 5m)? 
 
3. To further understand the construct of frailty in acute care, what other patient 




functional disability, education, living situation, perception of food intake, perceived 
nutritional health, barriers to food intake)? 
 
Predictive Validity of Frailty Indicators in Acute Care with Respect to LOS 
 
1. A) What is the predictive validity of handgrip strength (HGS) for the outcome of length 
of stay (LOS)?  
 
Ho: HGS does not add significant predictive value to models predicting LOS 
 
Ha: HGS does add significant predictive value to models predicting LOS 
 
B) What is the predictive validity of 5-metre timed walk (5m) for the outcome of length 
of stay (LOS)? 
 
Ho: 5m does not add significant predictive value to models predicting LOS 
 
Ha: 5m does add significant predictive value to models predicting LOS 
 
 
2. What are the best cut-off points for handgrip strength (HGS) using length of stay (LOS) 
as the outcome?  
 
3. Is the ≥6 or the > 5 second cut-point for the 5m appropriate for use in acute care (e.g. is 
sensitivity and specificity sufficient as compared to other cut-points)?  
 
Predictive Validity of Frailty Indicators in Acute Care with Respect to QOL 
 
1. A) What is the predictive validity of HGS for the outcome of quality of life (QOL) during 
and post-discharge from acute care? 
 
Ho: HGS does not add significant predictive value to models predicting QOL in hospital, 
or post-discharge.  
 
Ha: HGS does add significant predictive value to models predicting QOL in hospital, or 
post-discharge 
 
B) What is the predictive validity of 5m for the outcome of quality of life (QOL) during 
and post-discharge from acute care? 
 
Ho: 5m does not add significant predictive value to models predicting QOL in hospital, or 
post-discharge.  
 






Chapter 4: Feasibility of Frailty Indicators in Acute Care 
4.1 Introduction 
Frailty has recently been defined as “a medical syndrome with multiple causes and 
contributors that is characterized by diminished strength, endurance, and reduced physiologic 
function that increases an individual's vulnerability for developing increased dependency and/or 
death” (Morley et al., 2013 p. 393). This group also concluded that: frailty is an important 
medical syndrome and all persons >70 years of age should be screened for frailty (Morley et al., 
2013). It is currently estimated that over 1 million Canadians are frail (Hoover, Roterman, 
Sanmartin & Bernier, 2013). Prevalence rates for frailty range from 10-20% of community 
dwelling older adults (>65 years), with higher rates among women than men (Collard, Boter, 
Schoevers & Oude Voshaar, 2012; Song, Mitnitski & Rockwood, 2010). Although frailty is not 
unique to older adults, frailty rates increase substantially with age (Fried et al., 2001; Song et al., 
2010; Collard et al., 2012).  Statistics Canada predicts that by the year 2036, nearly 1 in 4 
Canadians will be over the age of 65 (Statistics Canada, 2015). With a large proportion of the 
Canadian population at risk of being frail, screening and measuring frailty in a reliable manner is 
essential. Furthermore, if frailty is to be screened in all patients over the age of 70 years, then 
acute care is an important setting in which screening can and should occur with feasible 
indicators. 
Much like the conceptualization of frailty, methods for assessing and screening for frailty 
have only recently been discussed by experts (Morley et al., 2013). Physicians have 
recommended a variety of screening tools, however, most rely on lengthy, subjective interview 
questions (Morley et al., 2013). Additionally, no current frailty-screening tools have sufficient 




Health Study Frailty Screening Measure includes a battery of objective measures, which may be 
a starting point for feasible use in acute care. One of the measures included is hand grip strength 
(HGS), which is measured clinically using a dynamometer to provide an overall measure of 
muscle strength (Bohannon n.d, Roberts et al., 2011). It has been suggested that HGS is the most 
useful single indicator of frailty (Syddall et al., 2003). HGS values have been used in the past to 
determine or predict a number of different health outcomes, including: mobility, cognition, 
mortality, functional status and hospitalization (Rijk et al., 2016).  HGS has also been found to 
be an indicator of weight loss (Norman et al., 2011; Flood et al., 2015), another component of the 
phenotype definition of frailty (Fried et al., 2001, Jeejeebhoy, 2012). 
 Another tool included in the Cardiovascular Health Study Frailty Screening Measure is 
gait speed. Fried’s phenotype model suggests that gait speed is an indicator of frailty, and 
research has confirmed this, reporting that slow gait speed (i.e., > 6 seconds during a timed 5m 
walk test) has successfully characterized older adults who have experienced adverse outcomes, 
such as frailty (Afilalo et al., 2010; Clegg et al., 2013; Wilson et al., 2013). Gait speed has also 
been shown to be associated with or predict a variety of health related outcomes, including: 
physical performance and incidence of falls (Scott et al., 2014), ambulation (Elbers et al., 2013), 
survival among cardiovascular patients (Chiaranda et al., 2013), and dyspnea and health related 
quality of life (HRQOL) among COPD patients (Kon et al., 2013). Additionally, gait speed has 
been determined to be a simple and effective measure in identifying those at higher risk of 
mortality and major morbidity in hospital (Afilalo et al., 2010). With these findings in mind, it 
should be noted that the feasibility of the 5m walk (5m) in acute care has not been adequately 
addressed in the literature. If frailty is considered to be an important predictor of acute care 




patients can and cannot complete these measures is not known, and needs to be addressed in 
order to understand the feasibility of these tools.  Furthermore, if HGS and 5m are feasible 
indicators for acute care patients, further conceptualizing the construct of frailty as measured by 
these indicators and its covariates is worthwhile to determine potential treatment options such as 
nutritional care.  
This study will determine the feasibility of two potential frailty indicators for use in an 
acute care patient population and how they are associated with relevant patient characteristics to 
further understand the frailty construct in this population.  Data collected on HGS and 5m in a 
large acute care nutrition study provided the opportunity to answer the following research 
questions: (1) Is there a difference in completion rate between HGS and 5m in medical patients; 
(2) what patients (e.g., younger, male etc.) are more likely to be able to complete each indicator 
(HGS and 5m), and (3): what patient characteristics are significantly associated with these 
indicators (e.g. nutritional status and perceived functional disability, education, etc.)?  
4.2 Methods  
4.2.1 Sample and Participants 
More-2-Eat was a multi-site participatory action research study with a before-after time 
series design.  The primary objective of the study was to implement and evaluate the Integrated 
Nutrition Pathway for Acute Care (INPAC) in Canadian hospitals. Each site was led by an 
interdisciplinary team, which offered coaching and improvement strategies towards 
implementing nutrition care best practices. The study population were all patients on the chosen 
medical unit for implementation of INPAC at the: Royal Alexandra Hospital (Edmonton, AB), 




System, General Site (Niagara Falls, ON), and Ottawa Hospital (Ottawa, ON). There are two key 
aspects of data collection at the patient level; an audit of nutrition care practices for all patients 
on the unit during monthly audit days and a detailed assessment of nutrition, frailty, disability, 
quality of life and food intake on a subset of patients recruited each month. This latter data 
collection was used for this study. There were 1250 detailed patient data collections over a 15-
month period for analysis. The proportion of males and females in the detailed patient data 
collection was not significantly different from the proportion in the INPAC audit data collection 
(45% male, 55% female vs. 48% male, 52% female respectively) (z=1.90, p=0.054). However, 
the mean age in the detailed patient data collection was lower than the INPAC audit data 
collection (68.5 years vs. 73.4 years (t=9.96, p<0.0001; 95% CI (3.99,5.88)); 66.9 years for 
males and 69.8 years for females vs. 72.0 years for males and 74.8 years for females 
respectively), indicating that the sample used for this analysis is slightly younger than the general 
medical unit population, potentially due to the eligibility criteria described below. 
The eligibility criteria were driven by the primary objectives of the More-2-Eat study and 
for the detailed patient collection were as follows: 1) no cognitive impairment as per admission 
assessment by nursing; 2) spoke English (or French at Ottawa site); 3) consumed an oral diet, 
however supplemental enteral or parenteral nutrition were allowed; 4) likely to return home to 
the community; and 5) provided written consent to participate. The sampling design was single 
stage and participants were chosen through a quasi-random sampling process. Research 
assistants were instructed to identify which patients were eligible to participate in the study, and 
then starting at one end of the unit (first room, first bed), recruit patients until they had met their 
quota for the month. In the developmental phase (4 weeks), 40 patients per month (~10/week) 




months. For the following week/month of collection, research assistants were instructed to start 
at the bed number in which they last stopped in the prior week/month. They were also reminded 
on the importance of recruiting less well individuals and frail older adults as they are often 
neglected in research, and will likely encompass more of the patient reported outcome measures 
included in the study.  
4.2.2 Data Collection and Measures  
To address the research questions, only data from the detailed patient data collection was 
used. This includes demographics, primary admission diagnosis, length of stay, nutritional risk 
(and diagnosis of malnutrition if relevant), an estimate of a single meal’s food intake, barriers to 
food intake, self-reported quality of life, self-reported disability, frailty indicators, patient 
reported perceptions on adequacy of food intake and nutritional health, and nutrition care 
provided in the hospital at the time of the data collection. All data were typically collected over 
one to three days for each patient. Items used in this analysis included: handgrip strength (HGS), 
five meter timed walk (5m), subjective global assessment (SGA), perceived functional status 
(Nagi scale), demographics, and reasons for non-completion of assessments.  HGS was repeated 
for some patients on the day of discharge if this was feasible (i.e. notice was provided and the 
assessors were available to collect the measure) and if it was at least 48 hours since the first 
measure; this was done to capture current frailty status prior to discharge that may have changed 
due to hospitalization and/or treatments. HGS at admission will only be used in this analysis. 
Clinical dietitians were seconded from their regular duties at the hospital to complete all 
data collection as researchers. Training was in-person and a detailed manual was provided to 
support consistency in procedures. Monthly phone call meetings also supported consistency in 




research staff. These researchers approached a patient for informed consent, shortly after they 
were admitted and determined to be eligible. On units where they were considered part of the 
‘circle of care’ they were allowed to directly recruit patients; where the dietitian was solely 
seconded for the research and not practicing on the unit, nursing staff determined eligibility and 
did the initial approach as per the ethics protocol to determine if the patient was interested in 
participating in the study. Final recruitment and written consent with eligible patients were 
completed by these research dietitians.  
To measure HGS, the research dietitian was trained on the Southampton protocol for 
HGS using a Jamar hydraulic hand dynamometer J000105 (Roberts et al., 2011). This protocol 
involves patients being seated in a chair with back support and arms (Roberts et al., 2011). 
However, if patients were not able to transfer from their bed to a chair, the measurement was to 
be taken in bed (Keller, 2015). The research dietitian demonstrated how to use the hand 
dynamometer and explained that tightly gripping the handle gave the highest score This measure 
was performed in the patient’s dominant hand for three trials; however, where an intravenous 
line was present in that arm, patients could use the opposite arm instead. All values were 
recorded (in kg), including the hand in which the test was performed. 
The 5m-walk assessment was performed in an unobstructed, well-lit, predetermined area 
of the hospital, where patients were asked to walk at a comfortable pace between a previously 
determined 0 and 5-meter marker on the floor (Afilalo et al., 2010). Once the researcher said 
‘go’, the timer was started with the first footfall over the 0-meter line, and the timer was stopped 
with the first footfall over the 5-meter line.  If the patient was able, the assessment was repeated 
three times, with a rest period provided between trials to allow the patient to recuperate.  The 




completed by the physiotherapy team on the unit. For both HGS and 5m, if patients were unable 
to complete the assessment, the reason for non-completion (non-ambulatory/cannot transfer, too 
weak, other) was also recorded (Keller, 2015).  
Nutritional status was assessed after a patient had been screened ‘at risk’ based on the 
Canadian Nutrition Screening Tool (CNST) (Laporte et al., 2015); thus a portion of the patients 
who completed this data collection were deemed well-nourished and the subsequent diagnosis of 
malnutrition with SGA was not completed. Nutritional status was determined based on the 
completion of the SGA.  The SGA is a tool used to diagnose malnutrition and is a valid 
assessment for acute care (Detsky et al., 1987, Fontes et al. 2014, Sheean et al. 2013). The SGA 
assesses dietary intake, weight, gastrointestinal symptoms and other risk factors for poor intake, 
functional capacity and metabolic requirements, presence of edema, fat and muscle masses. 
Patients were then classified as either well nourished (A), mildly/moderately malnourished (B), 
or severely malnourished (C) (Detsky et al., 1987). Additionally, all patients who were deemed 
severely malnourished (C) were referred to a unit registered-dietitian (RD) for further assessment 
and treatment (Keller, 2015). Patients were also asked their perception of the adequacy of their 
food intake and the quality of nutritional health. This first question involved asking “in general, 
do you think you are currently eating _________ to meet your body’s needs?” and respondents 
could choose “more than enough, enough, not enough”. The perceived adequacy of nutritional 
health question asked, “in general, would you say your nutritional health is currently…” and 
respondents could choose between “excellent, very good, good, fair or poor”.   
Perceived functional status was assessed using the 7-item Nagi scale, which suggests that 
significant disability is present with any self-reported difficulty in performing ≥3 of the 7 items 




various daily activities (pulling or pushing a large object, bending over, crouching, kneeling, 
raising arms over head, etc.). Respondents can then choose between “no difficulty, some 
difficulty, and great deal of difficulty/cannot do”, the latter two indicating perceived disability in 
completing that particular task. Questions on ability to carry out daily functions using this 
standardized scale were posed by the research associates. The SF-12 questionnaire was used to 
assess quality of life, and asks questions pertaining to physical health, emotional health, pain, 
and social experiences (Ware et al., 1995).  Food intake was used in these analyses, and was 
collected via the My Meal Intake Tool (MMIT) (McCullough & Keller, 2016). The MMIT 
assesses food intake at a single meal (McCullough & Keller, 2016). The tool can be completed 
by the patient, a family member or staff member, and indicates whether a person completed 0%, 
25%, 50%, 75%, or 100% of their food/beverages (McCullough & Keller, 2016). The total 
number of barriers to food intake as reported on the Mealtime Audit Tool (MAT) (McCullough, 
J., Marcus, H., & Keller, H., 2017) was also used for these analyses. The MAT is also self-
reported, and asks patients about the mealtime experience (e.g. Did the meal come at an 
appropriate time? Did you get the food that you ordered? Were your meals appetizing?) 
(McCullough, J., Marcus, H., & Keller, H., 2017).  The patient then responds yes/no and all “no” 
responses are added to indicate a summary score of barriers experienced (McCullough, J., 
Marcus, H., & Keller, H., 2017).  
Relevant demographics used in this analysis were either collected from the health record 
or asked of the patient and included: sex, age, primary admission diagnosis, highest level of 
education, and living situation. Length of stay was collected from the admission database for the 
unit. Admission diagnosis was categorized as cardiovascular, gastrointestinal, respiratory, 




to graduated secondary school; some post-secondary to post grad; and other/don’t know. Living 
situation was categorized as: alone; with spouse; with spouse and other family; with other family 
or friends; and other.  
 University of Waterloo (ORE #20590) and site ethics boards: Niagara Health Ethics 
Board (2015-07-001), Ottawa Health Science Network Research Ethics Board (20150345-01H), 
Health Research Ethics Board of the University of Alberta (Pro00056577), Regina Qu’Appelle 
Health Region Research Ethics Board (REB-15-68), University of Manitoba Health Research 
Ethics Board (H2015: 208) and Concordia Hospital Research and Ethics Committee (H2015: 
208), approved and provided clearance for this research study. Data collection directly from 
patients or staff required informed written consent, which was attained prior to data collection. 
4.2.3 Data Analysis  
 A secondary data analysis was performed. Data was analyzed using SAS Studio 9.4 for 
Windows.  The sample characteristics were descriptively presented as proportions and 
means/medians with standard deviations. Perceived functional status was collapsed into a binary 
score with two categories: no disability and disability (≥3 on the Nagi scale). Nutritional status 
was also collapsed into two categories: well-nourished (no risk/SGA A) and malnourished (SGA 
B/C). Proportions completing 5m or HGS were determined. A Z-test was conducted to determine 
significant differences in the proportion of completion rates between HGS and 5m walk 
measures. In order to determine whether categorical variables such as sex, perceived functional 
status, nutritional status, admission category, and site number were associated with completion 




 Nonparametric tests were used with 5m walk as it was not normally distributed, whereas 
HGS was normally distributed. To determine whether continuous variables such as age and LOS 
were associated with the completion of 5m, a non-parametric equivalent of a t-test was used 
(Mann-Whitney U test), whereas a t-test was used to analyze those variables with HGS.  
The 5m walk assessment uses a cut point of ≥6 seconds to indicate a dichotomous frail/not-frail 
outcome (Afilalo et al., 2010); this dichotomization was used to determine associations with 
categorical patient characteristics (e.g. sex, nutritional status). T-tests were performed to 
determine the association between continuous HGS values and dichotomous nutritional status 
and perceived disability categories. An ANOVA was used to compare education/living 
situation/perception of eating enough/perceived current nutritional health to continuous HGS 
values. Non-parametric equivalent tests (Kruskal Wallis) were used for continuous 5m values 
with these categorical variables.  95% confidence intervals and a p-value of 0.05 were used to 
determine statistical significance throughout.   
4.3 Results 
The M2E sample included 1250 patients with detailed data collection from 5 sites for this 
analysis. The sample included 45% males, and 55% females. The mean age was 68.5 years 
(SD=15.28). Table 1 provides further characteristics of participants. The mean LOS was 12.7 
days (SD=13.20), and 30% of patients had longer than the mean LOS for this sample. Based on a 
mean LOS of 7 days indicated in current literature (CIHI, 2014), 54% of this sample had a stay 
longer than this published mean. However, the CIHI mean LOS was age adjusted, and was not 
exclusive to medical patients. In this sample, 31% (389/1248) of patients were screened at risk, 




Of those at risk, 38% were categorized as SGA A, 48% SGA B, and 14% SGA C. The mean 
Nagi score was 4/7, and 79% had a score of ≥3 indicating that a perceived disability was present.  
 Of the 92% who were able to complete the HGS assessment (n=1146), the mean score 
was 20.8 kg (SD=12.35). Of those who completed the first HGS measure, 99% of patients 
completed the second trial and 94% completed the third trial. Of those who completed the HGS, 
83% (n=955/1146) patients were reported to use their right hand, whereas 15% (n=174/1146) 
patients were reported to use their left (2% had missing data).  Reasons for non-completion of 
the HGS assessment included being too weak, not able to comply, or other (e.g. patient 
discharged before assessment completed). In contrast, only 43% (n=535/1250) of patients were 
able to complete the 5m. Of those completers, 97% were able to complete the second trial, and 
80% were able to complete the third trial. Those who were unable to complete the 5m reported 
reasons including difficulty with ambulation, dizziness, weakness, etc. The difference in 
proportion of completion for these potential frailty indicators was statistically significant 
(z=17.39, p=<0.00001). Of those who completed the 5m, the mean completion time was 8.98 sec 
(med=6.79 sec, SD=6.59). Finally, 62% of those who could complete the 5m were considered 
frail, as their completion time was ≥6 seconds (Table 1).   
Comparisons between completers and non-completers for HGS and 5m by patient 
characteristics are provided in Table 2. Age was associated with the completion of only the HGS; 
those who were unable to complete this measure were older than those able to complete (t=2.33, 
p=0.020).  Sex was significantly associated with completion rates of both the 5m (X2=20.69, 
p<0.0001) and HGS (X2=6.91, p=0.009) assessments, with a higher proportion of men 
completing both indicators. However, the proportion of female completers was closer to males in 




the 5m (completers=10.01 days (SD=9.70); non-completers =14.78 days (SD=15.03, p<0.0001)), 
but no difference was seen in LOS by HGS completion (p=0.39). Perceived disability was also 
associated with the completion of 5 m walk (X2=80.05, p<0.0001), with two-thirds reporting a 
disability being unable to do this measure. HGS completion was also associated with perceived 
disability (X2=4.85, p=0.028); however, only ~10% of those reporting a disability were unable to 
complete the assessment. Nutritional status (no risk/SGA A vs. SGA B/C) had a minimally 
stronger association with the completion of HGS (X2=3.88, p=0.049) than 5m (X2=3.72, 
p=0.054). The difference in proportion of completers and non-completers for both HGS and 5m 
were significantly different across sites and across admission diagnosis categories (p<0.0001). 
Site 2 had the highest proportion of non-completion for the 5m (73.59%), whereas site 4 had the 
highest proportion of non-completion for HGS (18.51%). Musculoskeletal admission diagnoses 
had the highest proportion of non-completion for both 5m (75.42%) and HGS (15.25%).  
Table 3 provides mean/median values for HGS and 5m for key sample characteristics. There 
was a significant difference in HGS (t=22.51, p<0.0001; 95% CI (12.53, 14.93)) and 5m scores 
(z=6.04, p<0.0001; 95% CI (1.16, 2.78)) across sexes. There was not a significant difference in 
5m scores and SGA categories (z=2.49, p=0.051; 95% CI (-1.17, 2.34)), but there was a 
significant difference between HGS scores and SGA categories (t=4.13, p<0.001; 95% CI (2.02, 
5.67)) (A/no risk vs. B/C), with malnourished patients having longer timed walk and lower 
(weaker) HGS. 5m and HGS scores were significantly worse when a perceived disability was 
present (z=-9.56, t=10.69, respectively; p<0.0001; 95 % CI (7.33, 10.63), (1.76, 3.18)). This 
association was also found when 5m walk time was dichotomized to determine frailty (≥6 sec); 
74.51% of those who were considered frail based on their 5m walk score reported a disability 




Patients with higher levels of education had a shorter timed walk (H=23.94, p<0.0001) and 
higher HGS values (F=9.56, p<0.0001). Those who lived alone or with other family members 
had significantly poorer HGS scores (p<0.0001) and 5m walk times (p=0.0002), as compared to 
those who lived with a spouse. Patients whose food intake was ≤50% had lower HGS scores (t=-
3.72, p=0.0002; 95% CI (-4.33, -1.34)) and slower 5m walk times (z=2.83, p=0.0023; 95% CI (-
2.01, -0.05)). Patients who believed they were not eating enough to meet their body’s needs had 
lower HGS scores (F=4.29. p=0.014); however, they did not have significantly longer 5m walk 
times (p=0.31).  Patients who believed they had better current nutritional health had minimally 
higher (stronger) HGS values and longer walk times than those who believed their current 
nutritional health was poorer, however, these differences were not statistically significant 
(p=0.051; p=0.84). Finally, patients who experienced more barriers to food intake had lower 
(weaker) HGS values. This difference was statistically significant (F=4.64, p=0.010). No 
statistically significant differences were seen for 5m walk scores and those who experienced 
more mealtime barriers (H= 2.96, p=0.23); however, trends suggest the same association, as 
those who were slower tended to have more mealtime barriers. 
4.4 Discussion 
 Screening is meant to be a quick and easy measurement to determine the likelihood of a 
condition (Kondrup et al., 2003). To be of greatest utility for case finding, a screening tool 
should be completed on the entire target population, and in this case, acute care medical patients. 
This study has identified that the 5m walk is likely not a suitable measure for screening of frailty 
in acute care, as less than half of patients could complete this measurement, as many patients felt 
they were too fatigued, weak, dizzy, etc. to get out of bed. In addition, the difference in sex 




unsuitability of 5m as a potential screening tool, as the acute care setting requires a screening 
tool that can be used by all (Kondrup et al., 2003). Lack of ability to complete 5m (Table 2) was 
associated with patient reported disability and diagnosis. The former, points to the potential for 
5m to capture longstanding frailty, while the latter may suggest that the acute medical status is 
what is being signaled by the inability to do this measure. Prior research has shown that the 5m is 
in fact reliable and feasible in a community-dwelling sample of older adults (Tiedemann, et al. 
2008), indicating that there is potentially a need to consider different indicators for screening 
frailty in different settings. A significantly longer LOS, and a high proportion of perceived 
disability was seen in those who could not complete the 5m, indicating that perhaps completion 
status of the 5m in and of itself, rather than slow gait speed could be a helpful indicator of frailty 
or other patient reported outcomes. 
 Almost the entire sample was able to complete the HGS measure, demonstrating that it is 
a more feasible tool than 5m to use in acute care medical patients. Although age was a factor in 
the completion of HGS, the mean age of the group of completers was 68.2 years, indicating that 
the tool is still feasible for use among older adults (>65 years). In terms of feasibility by sex, 
HGS also had significantly higher completion rates among males. That being said, the proportion 
of female completers was much closer to the proportion of male completers for HGS than the 
5m. Nutritional status as measured by SGA was barely significantly associated with HGS, and 
not with 5m completion (Table 2). This is an important finding since, if clinicians are inclined to 
add a frailty indicator to their nutrition assessment to provide more information about the patient, 
it will be important that indicators be completed regardless of nutritional status. Furthermore, 




for both HGS and 5m, as assessments that are physical in nature would likely be difficult to 
complete for these patients.   
 There was considerable overlap between nutritional status and frailty (as measured by 5 
m), with 71% of those being malnourished, also being frail. The significant difference in HGS 
scores across nutritional status categories demonstrates construct validity for this particular 
frailty indicator, as frailty and malnutrition are theoretically related (Clegg et al., 2013; Chung et 
al., 2014; Jeejeebhoy, 2012; Savva et al., 2012; Studenski et al., 2003). The contention that 5m 
and HGS could be potential frailty indicators is also reinforced with significant differences in 
both HGS and 5m scores for those who did and did not perceive any disability, as disability is 
considered an outcome of frailty (Morley, 2017).  In addition, patients who had lower HGS 
scores typically had lower perceived and actual food intake, and experienced more barriers to 
food intake.  These associations suggest that HGS may be more closely aligned with malnutrition 
than 5m, and thus it is not surprising that some have considered HGS as a potential indicator for 
malnutrition (Norman et al., 2011) or even part of a comprehensive nutritional assessment 
(White et al., 2012). These associations between HGS and food intake and barriers to intake 
reinforce the potential utility of the use of HGS in acute care, as it may point to an individual 
who needs further interventions to support intake while in hospital. Both HGS and 5m were 
associated with lower levels of education and living situation, further confirming their potential 
as frailty indicators as education or socioeconomic status are associated with frailty (Hoogendijk 
et al., 2014; Laing et al., 2009). 
4.5 Limitations 
A limitation of this study is the eligibility criteria for recruitment of patients, as the 




other data collected in the M2E study.  The sample used in these analyses tended to be slightly 
younger patients than patients on this medical unit, who may have been different on their health 
and frailty characteristics as well. To mitigate this potential, research dietitians were informed of 
the importance of recruiting less well and frail older adults, as they are often underrepresented in 
research. Furthermore, there was likely some variability in terms of recruitment of patients due to 
the busyness of the project and capacity of hospital staff to do the initial recruitment of patients; 
this may have led to noted site differences in addition to type of medical patients eligible for 
recruitment.  
Other limitations include the potential for inter-rater differences when assessing HGS and 
5m. For example, some researchers may have been more diligent or motivating when 
encouraging patients to perform the assessments, resulting in superior scores or completion rates. 
However, researchers were trained on the appropriate protocol, and given detailed manuals and 
online support; there were site differences in completion rate and it is unknown if differences are 
due to patient type/unit issues or assessors. Another limitation to consider includes the fact that 
only the Southampton protocol for HGS was used, and many protocols for assessing HGS exist.  
However, training and protocol were standardized and the same dynamometer was used in all 
sites. Similarly, other measures used in this study could have been influenced by rater 
differences, resulting in inter-rater error.   
This study is only beginning to unpack how the identification of frailty in hospitals will 
change the care and treatment process. The identification of frailty in this setting ultimately 
affects health care utilization (e.g. LOS), outcomes (e.g. mortality), discharge decisions, and 
need for community services, and these should be addressed in future research. However, 




use of multiple sites. These strengths are important to consider, as the magnitude and rigor of this 
study are unparalleled in current literature and prior knowledge gaps on feasibility of measures 
could be addressed.  
4.6 Conclusion 
This analysis demonstrates that HGS is a more feasible indicator of frailty than the 5m in 
acute care medical patients, which included a large proportion of older adults. HGS had high 
completion rates across all sites, and was found to be feasible among older men and women (>65 
years). The 5m completion status in and of itself may be helpful to indicate frailty or other 
outcomes rather than the time taken to complete the test, as non-completion was associated with 
longer LOS and perceived disability. It is of particular interest that the completion of both 
measures was not significantly associated with SGA, suggesting that they can be completed 
regardless of nutritional status. This is important if clinicians wish to add a frailty indicator to the 
SGA to provide a representation of frailty in a patient. Further, the association between HGS and 
other indicators of nutrition such as lower perceived food intake and more barriers to food intake, 
suggests its potential utility in clinical nutrition assessment to identify patients who are more 
likely to have more challenges with food consumption.  Results from this rigorous secondary 
data analysis can be used to enhance the knowledge of researchers, health care providers and 
stakeholders regarding the identification of frailty in acute care. Given the growing population of 
older adults, their susceptibility to frailty and malnutrition, and their health care utilization, it is 








Table 1 - Characteristics of Patients in Acute Care 
Variable Mean Median SD 
Age (n=1250) 68.48 years 70.00 years 15.28 
HGS (n=1146) 20.82 kg 19.33 kg 12.35 
5M (n=535) 8.98 seconds 6.79 sec 6.59 
Nagi (n=1250) 4/7 4/7 1.90 
LOS (n=1233)1 12.71 days 8.00 days 13.20 
 % (n) 
Male 45 (560/1250) 
Female 55 (690/1250) 
LOS </= 7 days2  46 (565/1233) 
LOS >7 days  54 (668/1233) 
LOS </= 13 days  70 (864/1233) 
LOS > 13 days  30 (369/1233) 
Well nourished 





Self-reported Disability      
(Nagi scale ≥ 3/7) 
79 (983/1250) 
Frail (5M > 6 sec)  62 (334/535) 
1 (15 missing entries, 3 outliers removed)  
Abbreviations: HGS= Handgrip strength; 5M= Five meter timed walk; LOS=Length of Stay; SGA= 
























Table 2- Characteristics of Completers and Non-Completers of HGS and 5M Assessments 

































Male (n=560)  


































































































































































































1 15 missing entries, 3 outliers removed 2; Malnourished group includes: SGA Bs and Cs; 3Well-nourished group includes: No 







Table 3- Patient Characteristics Associated with HGS and 5M 
 HGS (n=1146) 5M (n=535) 
 Mean (SD) Median P value/ 
 95% CI 

































































































































































































































































































































































































1Well-nourished group includes: No risk and SGA A; 2Malnourished group includes: SGA Bs and Cs; Abbreviations: HGS= 












Chapter 5: Predictive Validity of Frailty Indicators in Acute Care with Respect to LOS 
5.1 Introduction 
In the 2012-2013 fiscal year, acute inpatient hospitalizations in Canada cost 24.4 billion 
dollars (CIHI, 2014). According to the Canadian Institute of Health Information (CIHI), in 2013-
2014 there were more than 2.9 million acute care hospitalizations in Canada, and after adjusting 
for age, the average length of hospital stay (ALOS) was 7.0 days (CIHI). Currently, 10% of the 
acute care population is experiencing length of stays (LOS) longer than 30 days (CIHI, 2015). 
The high cost of acute care hospitalizations and efforts to reduce LOS indicates that LOS is an 
important acute care outcome. Identification of factors that predict LOS is relevant to 
understanding how improvements can be made in care processes to support an earlier discharge. 
Frailty is likely one of these factors. A variety of measures consistent with the frailty concept 
(e.g. weight loss, hand grip strength, gait speed, food intake, nutrition support in hospital) have 
been found to be associated with LOS (Allard et al., 2015; Shinkai et al., 2000, 2003; Sarkisian 
et al., 2001; Corbett, Dalton, Young, Silman & Shipley, 1993; Pichard et al., 2004). Yet, research 
on frailty per se as a predictor of LOS has been limited by use of complex measures that include 
subjective components, which are not easily used in clinical settings by non-experts (Morley et 
al., 2013). The Cardiovascular Health Study Frailty Screening Measure contains a battery of 
objective measures (including grip strength and gait speed), which may be a starting point in 
terms of determining feasible, single or joint indicators of frailty that can predict length of stay.  
Presently, few studies have explored the predictive validity between a single indicator of 
frailty and length of stay. Peel et al. (2014) investigated the predictive validity of gait speed for 
length of stay in post-acute transitional care for older adults white adjusting for age and sex. 




length of stay. However, this was a relatively small sample (n=351) from a single site, and was 
conducted in transitional care, rather than acute care. Additionally, this study did not use age or 
sex-specific cut-off points for 5m walk (5m) using LOS as the outcome and did not use the 
recommended cut-point of ≥6 seconds to indicate the presence of frailty (Afilalo et al., 2010). 
This cut-point needs to be tested to determine sensitivity (SE) and specificity (SP) for acute care 
using LOS as an outcome.   
Similarly, Kerr et al. (2006) conducted a small (n=120) clinical study with the aim of 
investigating associations between handgrip strength (HGS) and LOS, and found that a higher 
admission HGS was associated with increased likelihood of discharge (Kerr et al., 2006). 
However, no cut-off points were determined, limiting the practicality of using this measure in a 
clinical setting to identify those at risk for a longer LOS. Additionally, the small data set, lack of 
consideration of other covariates and limited generalizability of this study warrants further 
research on handgrip strength and length of hospital stay in a larger sample. Although research 
has been conducted on components of frailty and length of stay in a variety of specific patient 
populations, it is important to consider the potential association in a diverse medical population, 
while adjusting for covariates such as age. 
A key consideration in using a frailty indicator is the identification of cut-points that not 
only predict key outcomes, but also do not lead to such a high prevalence that they are not 
feasible (i.e. overly sensitive). Cut points for HGS have been established in the literature for 
related outcomes, including mortality, mobility and functional status (Rijk et al. 2016), but none 
have been created specifically for a general acute care population. Specifically, Sallinen et al. 
(2010) created cut points for HGS to screen community-living older adults (>55 years) for risk of 




developed cut points for HGS to predict clinically relevant weakness (measured by gait speed). 
These were derived from a large sample of 20,847 from a variety of health studies and clinical 
trials (Alley et al. 2014). The results showed that the best cut points to predict clinically relevant 
weakness were 26kg and 16kg for men and women respectively (Alley et al. 2014). Giulani et al. 
(2008) created a cut point from a sample of 1791 participants in assisted living. This study 
defined a cut point of 14kg as a HGS value to predict functional impairment. These cut-points 
derived in a variety of samples and associated with frailty concepts are potential starting points 
for identifying values useful in the acute care population as a measure of frailty.  
  This research aims to bridge this gap in the literature by addressing the following 
research questions: (1) What is the predictive validity of a) handgrip strength (HGS) and b) 5m 
walk (5m) for the outcome length of stay (LOS) when adjusting for other relevant covariates?  
(2) What are the best published cut-off points for HGS using length of stay LOS as the 
outcome?,  and (3) What is the sensitivity (SE) and specificity (SP) for the ≥6 second cut-point 
for the 5m for use in acute care using LOS as the outcome?  
5.2 Methods  
5.2.1 Sample and Participants  
More-2-Eat was a multi-site participatory action research study with a before-after time 
series design.  The primary objective of the study was to implement and evaluate the Integrated 
Nutrition Pathway for Acute Care (INPAC) in Canadian hospitals. Each site was led by an 
interdisciplinary team, which offered coaching and improvement strategies towards 
implementing nutrition care best practices. The study population were all patients on the chosen 
medical unit for implementation of INPAC at the: Royal Alexandra Hospital (Edmonton, AB), 




System, General Site (Niagara Falls, ON), and Ottawa Hospital (Ottawa, ON). There are two key 
aspects of data collection at the patient level (Keller et al., 2017); an audit of nutrition care 
practices for all patients on the unit during monthly audit days and a detailed assessment of 
nutrition, frailty, disability, quality of life and food intake on a subset of patients recruited each 
month. This latter data collection was used for this study.  
The eligibility criteria were driven by the primary objectives of the More-2-Eat study and 
for the detailed patient collection were as follows: 1) no cognitive impairment as per admission 
assessment by nursing; 2) spoke English (or French at Ottawa site); 3) consumed an oral diet, 
however supplemental enteral or parenteral nutrition were allowed; 4) likely to return home to 
the community; and 5) provided written consent to participate. The sampling design was single 
stage and participants were chosen through a quasi-random sampling process. Research 
assistants were instructed to identify which patients were eligible to participate in the study, and 
then starting at one end of the unit (first room, first bed), recruit patients until they had met their 
quota for the month. In the developmental phase (4 weeks), 40 patients per month (~10/week) 
was the quota, whereas in the implementation phase the quota was 20 patients per month for 12 
months. For the following week/month of collection, research assistants were instructed to start 
at the bed number in which they last stopped in the prior week/month. They were also reminded 
on the importance of recruiting less well individuals and frail older adults as they are often 
neglected in research, and will likely encompass more of the patient reported outcome measures 
included in the study.  
5.2.2 Data Collection and Measures  
Data from the patient demographic and health form from M2E resulted in the collection 




analysis and collected from the patient demographic and health form included: HGS, 5m, and 
LOS as well as key covariates. Clinical dietitians were seconded from their regular duties at the 
hospital to be M2E research associates and complete all data collection. Training for these 
research dietitians was in-person and a detailed manual was provided to support consistency in 
procedures. Monthly phone call meetings supported consistency in data collection and a virtual 
group via the Internet helped to address questions among these research staff. These researchers 
approached a patient for informed consent, shortly after they were admitted and determined to be 
eligible. On units where they were considered part of the ‘circle of care’ they were allowed to 
directly recruit patients; where the dietitian was solely seconded for the research and not 
practicing on the unit, nursing staff determined eligibility and did the initial approach as per the 
ethics protocol to determine if the patient was interested in participating in the study. Final 
recruitment and written consent were completed by these research dietitians. Data collection 
typically occurred early during the hospitalization (i.e. second or third day).  
HGS was collected by the site More-2-Eat research associates who were trained on the 
Southampton protocol for measuring HGS using a Jamar hydraulic hand dynamometer J000105 
(Roberts et al., 2011). This protocol involves patients being seated in a chair with back support 
and arms (Roberts et al., 2011). However, if patients were not able to transfer from their bed to a 
chair, the measurement was taken in bed (Keller, 2015). The research dietitian demonstrated how 
to use the hand dynamometer and explained that tightly gripping the handle gives the highest 
score. This measure was performed in the patient’s dominant hand for three trials; however, 
where an intravenous line was present in that arm, patients could use the opposite arm instead. 




The 5m assessment was performed in an unobstructed, well-lit, predetermined area of the 
hospital, where patients were asked to walk at a comfortable pace between a previously 
determined 0 and 5-meter marker on the floor (Afilalo et al., 2010). Once the researcher said 
‘go’, the timer was started with the first footfall over the 0m line, and the timer was stopped with 
the first footfall over the 5m line (Afilalo et al., 2010). If the patient was able, the assessment 
was repeated three times, with a rest period provided between trials to allow the patient to 
recuperate (Keller, 2015). The time was recorded in seconds on the data collection form.  At one 
site this measure was completed by the physiotherapy team on the unit.  
Length of stay was quantified as day of admission, to day of discharge and collected by 
the M2E research associate from the patient’s chart. For the purpose of determining sensitivity 
and specificity of published cut-points for HGS and 5m with respect to LOS, LOS was 
dichotomized into >/≤7 days categories, indicating above and below age-adjusted mean LOS, 
based on relevant literature (CIHI, 2014). Further, analyses were also completed using the 
median of this sample  >/≤13 days.  Other relevant variables collected and used in this analysis 
included sex, admission diagnosis, and age, all abstracted from the health record. Primary 
reasons for admission were categorized into disease specific groups (cardiovascular, 
gastrointestinal, respiratory, musculoskeletal, neurological, infection or other).  Nutritional risk, 
and where relevant, nutritional status was determined for all of these patients, either by the M2E 
research associate or unit staff as INPAC was implemented. The Canadian Nutrition Screening 
Tool (CNST) was used to determine nutrition risk.  For those at risk, the Subjective Global 
Assessment was used to diagnose malnutrition (Detsky et al., 1987), which includes information 
on dietary intake, weight, symptoms, functional capacity and metabolic requirements, as well as 




nourished (A), mildly/moderately or suspected of being malnourished (B), or severely 
malnourished (C) (Detsky et al., 1987). Additionally, all patients who were deemed severely 
malnourished (C) were referred to a unit registered-dietitian (RD) for further assessment and 
treatment.  Nutritional status was dichotomized for analysis. To include all patients in the sample 
in analyses ‘No nutritional risk’ (based on nutrition screening by the CNST) and SGA A were 
amalgamated into a well-nourished group, and SGA B and C categories were amalgamated to 
make up the malnourished group. Perceived functional status was assessed using the 7-item Nagi 
scale, which suggests that significant disability is present with any self-reported difficulty in 
performing ≥3 of the 7 items (Nagi, 1976). The Nagi scale asks respondents to choose their level 
of difficulty in performing various daily activities (pulling or pushing a large object, bending 
over, crouching, kneeling, raising arms over head, etc.). Respondents can then choose between 
“no difficulty, some difficulty, and great deal of difficulty/cannot do”, the latter two indicating 
perceived disability in completing that particular task. Questions on ability to carry out daily 
functions using this standardized scale were posed by the research associates.  
University of Waterloo (ORE #20590) and site ethics boards: Niagara Health Ethics 
Board (2015-07-001), Ottawa Health Science Network Research Ethics Board (20150345-01H), 
Health Research Ethics Board of the University of Alberta (Pro00056577), Regina Qu’Appelle 
Health Region Research Ethics Board (REB-15-68), University of Manitoba Health Research 
Ethics Board (H2015:208) and Concordia Hospital Research and Ethics Committee 
(H2015:208), approved and provided clearance for this research study. Data collection directly 





5.2.3 Data Analysis 
 A secondary data analysis was performed. Data was analyzed using SAS Studio 9.4 for 
Windows. To determine the predictive validity of frailty indicators (HGS and 5m) with respect to 
LOS (continuous), multiple linear regression analyses were performed, while relevant covariates 
were adjusted for. All theoretically relevant covariates were added to an initial model for the 
dependent variable LOS with the frailty indicator then included in a second model. Covariates in 
this analysis included: site, age, sex, primary reason for admission, and nutritional status. Initial 
sex effects were seen in the model, so further models were stratified by sex. The assumptions of 
linear regression were assessed by the examination of scatter plots, and a p-value of 0.05 and 
95% CI were used to determine statistical significance.  Correlation analyses were conducted to 
determine multi-colinearity among covariates.  Separate regression models were developed for 
HGS and 5m as continuous values.  The strength of the association of the frailty indicator was 
based on a likelihood ratio test (LRT) comparing the initial and second model to determine 
whether the addition of the frailty indicator added any significant predictive value to the model. 
A sensitivity analysis was conducted by including only readable HGS scores (n=846) (non-zero 
values in at least 1 trial) vs. all HGS scores (n=885). The difference between readable and all 
HGS scores was negligible; thus all HGS scores are presented in results. Models including HGS 
and 5m cut points together, as well as a combined HGS and 5m variable were also created (data 
not shown), but found to have no meaningful differences from single-indicator models shown in 
results.   
 Sensitivity and specificity analyses were also conducted to determine the best published 
cut-point for predicting LOS with HGS values and the established cut-point of ≥6 sec for 5m 




validity of outcome (Streiner, D. L. & Norman, G.R., 1995).  The only other specific cut-point 
found in the literature used to predict health related events in older adults was > 1 m/s (> 5m/s 
for the 5m) (Cesari et al., 2005). This cut-point was determined from a large sample (n=3047) 
with a mean age of 64.2 years. A variety of cut-points exist in the literature for HGS to indicate 
functional disability (Alley et al., 2014; Bahat et al., 2016; Giulani et al., 2008; Martin-Ponce et 
al., 2014; Sallinen et al., 2010; Yang et al., 2014). The cut-points chosen to indicate frailty in this 
study were from large, diverse samples (n>1700) that provided a range of cut-points and also 
considered the potential for sex-specific values. The cut-points for functional impairment by 
Giulani et al., 2008 (< 14 kg), Sallinen et al., 2010 (<37 kg for males, <21 kg for females), and 
Alley et al., 2014 (<26 kg for males, <16 kg for females) were used to indicate frailty in this 
study. No cut-points were derived in this sample as it was anticipated that the sample was 
potentially unrepresentative of medical patients in these hospitals due to the eligibility criteria  
(e.g. exclusion of persons with dementia and delirium) and it was also considered appropriate to 
evaluate current cut-points before creating new ones. The SE and SP of a given cut-point was 
qualitatively compared to other potential cut-points identified for that measure; higher SE and SP 
for a cut-point indicated an improved or better value for determining frailty in this sample. 
Prevalence based on cut-points is also presented. 
5.3 Results 
There were 1250 detailed patient data collections over a 15-month period for analysis.  
The proportion of males and females in the detailed patient data collection was not significantly 
different from the proportion in the INPAC audit data collection (45% male, 55% female vs. 
48% male, 52% female respectively) (z=1.90, p=0.054). However, the mean age in the detailed 




(t=9.96, p<0.0001; 95% CI (3.99,5.88)); 66.9 years for males and 69.8 years for females vs. 72.0 
years for males and 74.7 years for females respectively), indicating that the sample used in this 
analysis is slightly younger than the medical unit population in these 5 hospitals. 
The mean LOS was 12.71 days (SD=13.20), and 30% of patients had longer than average 
(13+ days) for this sample. Based on an age-adjusted average LOS of 7 days indicated in current 
literature (CIHI, 2014), 54% of this sample had longer than this average LOS. Almost all (92%) 
of the sample completed the HGS assessment (n=1146/1250), and 43% (n=535/1250) of patients 
were able to complete the 5m assessment.  
Table 4 summarizes the descriptive statistics and correlation results. Nagi score was 
correlated with both HGS (rho= -0.38, p<0.0001) and 5m (rho=0.38, p<0.0001), and therefore 
not included in regression models. HGS was negatively correlated with LOS (rho=-.11, 
p=0,0002), indicating that decreased grip strength was associated with a longer LOS, while 5M 
(rho= 0.18, p<0.001) was positively correlated with LOS (longer walk times associated with 
longer LOS). Site (F=4.98, p=0.0002), being malnourished (t=-5.72, p<0.0001) and admission 
diagnosis category (F= 5.93, p<0.0001) were also significantly associated with LOS.  Age and 
sex were considered theoretically relevant, and therefore added to the models regardless of 
statistical significance. Preliminary results showed a sex interaction, so further models were 
stratified by sex, and separate models were created for HGS, 5m.  
To determine the predictive validity of HGS and 5m with respect to LOS, all associated 
variables except for HGS/5m were included in an initial model, and then a second model was 
created including HGS/5m walk. Likelihood ratio tests indicated that HGS did add significant 
predictive value for both the male sex-stratified model (X2=18.62, p<0.0001) and the female sex-




predictive value for the male sex-stratified model (X2=3.9, p<0.05). In essence, final models 
indicate the additional predictive value of HGS/5m for LOS when adjusted for these meaningful 
covariates. As noted in these final models, the addition of HGS as an indicator of frailty 
significantly improved the predictive value of both the male and female sex-stratified models, 
whereas 5m was not useful to predict LOS across both sexes (Tables 6 and 7).  
Sensitivity and specificity analyses were conducted on HGS and 5M with various cut-
points identified in the literature to determine which were potentially most useful when 
considering the outcome of LOS in acute care patients. LOS was dichotomized for this analysis 
at 7 and 13 days. These results are summarized in Tables 8 and 9. The HGS cut-point with the 
highest SE was Sallinen (<37kg for men (SE=0.81; SP=0.27), <21 kg for women (SE=0.84; 
SP=0.25)). Using this cut-point, 77% of the males were considered frail, while 80% of the 
females were considered frail.  This high prevalence and the low specificity indicate that these 
sex-specific cut-points lack discriminatory power. The Giulani cut point (<14 kg) for males and 
females had the lowest sensitivity, and highest specificity (SE=0.32, SP=0.75), and only 30% of 
the sample were considered frail. The Alley cut-point (<26 kg for males, <16 kg for females) 
produced the best balance of sensitivity and specificity (SE=0.47, 0.61; SP=0.57, 0.49 
respectively) and the prevalence of frailty was 41% and 57% for males and females respectively. 
However, the AUCs for all cut-points indicate that HGS was not sufficient to predict LOS while 
adjusting for age (Table 8). The Afilalo (≥6 s) cut-point for 5m had an SE=0.68, SP=0.43 with an 
AUC=0.55, while the Cesari (2005) (>5 s) had a SE=0.84, SP=0.21, and AUC=0.52. Both of 
these cut-points do not have sufficient discriminatory value and prevalence was 62% and 81% 




completion vs. non-completion produced SE=0.34, SP=0.57, AUC=0.56 but had the poorest 
sensitivity for this frailty indicator for this sample.  
5.4 Discussion  
 Experts agree that screening for frailty needs to occur in hospital settings, especially 
among older adults (>70 years) (Morley et al., 2016). Objective, physical performance measures, 
which are more focused on the functioning of the individual are preferable to subjective 
evaluations for measuring frailty, especially in a clinical or hospital setting (Cesari et al., 2016). 
These tools also need to be relevant for predicting important outcomes such as LOS to support 
clinical decision-making.  
 Correlations between HGS/5m and LOS were significant and in the anticipated direction, 
confirming that lower HGS values and longer 5m walk times are associated with a longer LOS. 
Yet, an association is not sufficient to demonstrate the relevance of a new tool in clinical 
practice. The inclusion of a new clinical measure on all patients needs to demonstrate at 
minimum that it adds value to treatment decisions and is associated with patient outcomes, as 
well is responsive to treatment. This analysis demonstrated that HGS provided additional 
predictive value for LOS when adjusting for other covariates that would be collected in a clinical 
setting, whereas 5m did not provide this additional predictive value for females. Based on this 
analysis, HGS appears to be an adequate tool for measuring frailty and predicting clinical 
outcomes such as LOS in this setting.  The overall low R2 values of the predictive models may in 
part be attributed to the amount of variance inherent in the outcome (LOS). It is recommended 
that further predictive validity of these tools be assessed for other clinical outcomes to determine 
their utility while adjusting for other relevant covariates (e.g. disease severity) that likely 




If objective tools are to be used in clinical practice, they require a score or cut-point upon 
which decisions are made with respect to treatment options. Development of new cut-points for 
HGS and 5M based on this sample was not considered appropriate, as eligible patients included 
in this data collection were not representative of all medical patients (i.e. no delirium or 
dementia).  Thus, this analysis was focused on determining if current cut-points would be 
appropriate when considering the outcome of LOS. The cut-points chosen in this study to 
identify frailty with HGS have been used in the past to determine functional disability and 
mobility limitations (Alley et al., 2014; Giulani et al., 2008; Sallinen et al., 2010) and are below 
the 50th percentile HGS reference values for similar age categories (Stats Canada, 2007 to 2013 
Canadian Health Measures Survey (reference equations)), indicating that they are likely 
capturing less well individuals. However, these existing HGS and 5m cut-points for frailty do not 
appear to be useful for predicting LOS, as all cut-points produced SE/SP/AUC values <0.70. 
These results reveal that if further work is pursued with these objective measures cut-points need 
to be improved and re-assessed to capture and predict clinical outcomes such as LOS in an 
unbiased sample.  
This analysis also warrants further exploration of whether or not HGS is truly measuring 
the entire construct of frailty. Criterion and construct validity testing needs to be done in further 
research to determine the validity of these tools for this purpose. The Clinical Frailty Scale (CFS) 
is a subjective tool that has been shown to be effective and valid for measuring frailty, and 
provides important predictive information about death, and other adverse outcomes (Rockwood 
et al., 2005). Current work is being done to improve the utility of the CFS. The Frailty 
Assessment for Care-planning Tool (FACT) is a modification of the CFS that can be used by 




on collateral history instead of self-report, and combines some scores for easier scoring without 
losing information pertinent to clinical decision making (Moorehouse et al., 2017 not published). 
This tool has been shown to be more closely associated the Frailty Index (Fried, 2001) than the 
CFS.  Both the CFS and FACT tools may be a starting to point to determine the 
criterion/construct validity of single objective measures such as HGS or 5m.  Further, research 
using HGS cut-points to influence decision-making is needed to determine if it adds value to 
clinical assessment and treatment. 
5.5 Limitations 
A limitation of this study is the eligibility criteria for recruitment of patients, as the 
resulting sample was not representative of all medical patients on this unit when compared to 
other data collected in the M2E study. The sample used in these analyses tended to be slightly 
younger patients than the medical patients in these 5 hospital units, who may have been different 
on their health and frailty characteristics as well. However, researchers were informed on the 
importance of recruiting less well and frail older adults, as they are often underrepresented in 
research and the average age is consistent with prior work on medical patients (Bowles et al., 
2014; Buendgens et al., 2014; Donzé, Bates & Schnipper 2013). Furthermore, there was some 
variability in terms of recruitment of patients due to the busyness of the project and capacity of 
hospital staff to complete initial recruitment. Systematic error may also be present as a result of 
some missing data.  Other limitations include the potential for inter-rater differences when 
assessing HGS and 5m. For example, some researchers may be more diligent or motivating when 
encouraging patients to perform the assessment, resulting in superior scores. However, 
researchers were trained on the appropriate protocol, and given detailed manuals and online 




includes the fact that only the Southampton protocol for HGS was used, and many protocols for 
assessing HGS exist; specific protocols for unwell, acute care patients who cannot transfer easily 
from bed are warranted. In addition, LOS as the outcome variable being predicted has 
implications for interpretation, as many factors contribute to LOS. That being said, a fully 
adjusted analysis considering diverse covariates to determine the independent effect of HGS and 
5m on LOS was not the objective of this analysis, but rather to demonstrate predictive validity.  
5.6 Conclusion  
HGS appears to add significant additional predictive value with respect to predicting 
LOS, and is thus a more appropriate tool to use on both male and female acute care patients than 
the 5m. Additionally, if HGS is to be pursued for use in clinical practice, better cut-points than 
those available in the current literature and specific to acute care patients are needed. Given the 
growing population of older adults, their susceptibility to frailty, and their health care utilization, 
it is critical that further research be conducted to identify frailty in the clinical setting and how 


















Table 4- Correlation with LOS 
 
* p<.05  **p<.01 ***p<0.001 
1 15 missing entries, 3 outliers removed; Abbreviations: HGS= Handgrip strength; 5M= Five meter timed walk; 



























 Variable Mean (SD) Pearson Correlation 
LOS (n=1233)1 12.31 days (13.20) ---- 
LOS (sex stratified) M: 12.88 days (13.82) 
F 12.58 days (12.68) 
 
HGS (n=1146) 20.82 kg (12.35) -0.11** 
HGS (sex stratified) M: 28.26 kg (12.45) 
F: 14.54 kg (8.01) 
 
5m (n=535) median=8.98 s (6.59) 0.18*** 
5m (sex stratified) M: median=7.80 s (5.70) 
F: median=10.27 s (7.24) 
 
Age (n=1250) 68.48 years (15.28) 0.070 
Age (sex stratified) M: 66.91 years (15.09) 
F: 69.76 years (15.32) 
 
Nagi (n=1250) 4/7 (1.90) 0.22*** 
Nagi (sex stratified) M: 3.68/7 (1.99) 









* p<.05  **p<.01 ***p<0.001 
1Malnourished group includes: SGA Bs and Cs; 2Well-nourished group includes: No risk and SGA A 
Abbreviations: HGS= Handgrip strength; 5M= Five meter timed walk; LOS=Length of Stay; M=Male; F=Female
Variable Mean LOS Test Statistic 
Sex 
























Nutritional Status  



























Table 6- Regression Analysis of LOS with Covariates and for HGS Stratified by Sex 
 Model 1 Model 2 




P value Parameter estimate   
(95% CI) 
P value Parameter 
estimate   (95% 
CI) 
P value Parameter estimate     
(95% CI) 
P value 
HGS N/A N/A N/A N/A -0.25 (-0.4,-0.1) <.0001 -0.18 (-0.3, -0.02) 0.02 








0.76 (-3.5, 5.0) 
-2.16 (-6.3,1.9) 
1.14 (-2.7,5.0) 
-3.73 (-8.2, 0.7) 
----- 
0.12  
-1.89 (-5.8, 2.0) 
-5.34 (-8.8, -1.9) 
-0.83 (-4.3, 2.6)  
-3.73 (-7.2, -0.3) 
----- 
0.009  
-0.56 (-4.7, 3.6) 
-5.65 (-9.9, -1.4) 
0.81 (-3.0, 4.6) 
-4.82 (-9.2, -0.5) 
----- 
0.005  
-2.44 (-6.4, 1.5) 
-7.82 (-11.9, -3.7) 
-1.32 (-4.8, 2.1) 














6.15 (3.1, 9.2) 
<.0001  
----- 














-0.54 (-5.0, 4.0) 
4.01 (-1.9, 9.9) 
0.32 (-4.7, 5.4) 
3.90 (-0.9, 8.7) 




-1.89 (-6.5, 2.7) 
-1.90 (-5.6, 1.8) 
8.90 (4.7, 13.1) 
-2.05 (-6.5, 2.4) 
0.01 ( -4.2, 4.2) 
0.29 ( -3.4, 4.0) 
<.0001  
----- 
-1.95 (-7.4, 3.5) 
-0.02 (-4.4, 4.4) 
4.87 (-0.9, 10.7) 
0.73 (-4.2, 5.7) 
3.36 (-1.3, 8.1) 
0.87 (-3.4, 5.2) 
0.25  
----- 
-1.52 (-6.1, 3.0) 
-1.68 (-5.4, 2.0) 
8.66 (4.4, 12.9) 
-1.99 (-6.5, 2.5) 
0.15 (-4.1, 4.4) 
0.35 (-3.4, 4.1) 
<.0001 
R2 0.067 0.11 0.10 0.11 
Log liklihood -2085.19 -2383.97 -2074.88 -2381.37 
LRT N/A N/A X2=18.62, p<0.0001 X2=5.2, p<0.05 
Abbreviations: HGS= Handgrip strength; 5M= Five meter timed walk; LOS=Length of Stay; Adm.Cat.= Admission Category; Cardio.= Cardiovascular; Gastro.= 









Table 7- Regression Analysis of LOS with Covariates and for 5m Stratified by Sex 
 Model 1 Model 2 
Male (n=278) Female (n=254) Male (n=278) Female (n=254) 
Parameter 
estimate    (95% 
CI) 
P value Parameter estimate     
(95% CI) 
P value Parameter 
estimate    (95% 
CI) 
P value Parameter 
estimate   (95% 
CI) 
P value 
5m (s) N/A N/A N/A N/A 0.18 (-0.01,0.4) 0.06 0.14 (-0.06, 0.3) 0.17 








2.20 (-1.4, 5.8) 
-3.77 (-7.7, 0.2) 
0.89 (-2.4, 4.1)  





-5.80 (-11.5, -0.1) 
-10.18 (-15.5, -4.9) 
-7.22 (-12.1, -2.4) 
-8.52 (-13.7, -3.3) 
----- 
0.003  
2.48 (-1.1, 6.1) 
-3.52 (-7.5, 0.4) 
1.35 (0.8, 12.0) 
-2.50 (-6.2, 1.2) 
----- 
0.007  
-5.47 (-11.2, 0.3) 
-9.67 (-15.0, -4.3) 
-7.14 (-12.0, -2.3) 








2.53 (-0.1, 5.2) 
0.06  
----- 
3.23 (-0.2, 6.7) 
0.07  
----- 
1.90 (-0.8, 4.6) 
0.17  
----- 













-0.20 (-4.7, 4.3) 
-0.42 (-3.7, 2.9) 
6.33 (0.7, 12.0) 
-0.77 (-4.5, 3.0) 
3.20 (-0.6, 7.0) 




1.73 (-3.9, 7.3) 
-0.02 (-4.9, 4.8) 
14.48 (8.6, 20.3) 
0.99 (-4.6, 6.6) 
-0.72 (-6.2, 4.8) 
0.96 (-3.9, 5.8) 
<.0001  
----- 
0.12 (-4.4, 4.6) 
-0.12 (-3.4, 3.1) 
6.41 (0.8, 12.0) 
-0.26 (-4.0, 3.5) 
3.40 (-0.4, 7.2) 
1.75 (-1.5, 5.0) 
0.12  
----- 
1.54 (-4.1, 7.1) 
-0.16 (-5.0, 4.7) 
13.21 (7.1, 19.3) 
0.47 (-5.1, 6.1) 
-0.71 (-6.2, 4.8) 
0.66 (-4.2, 5.5) 
 
0.0007 
R2 0.097 0.19 0.11 0.20 
Log Liklihood -958.66 -945.16 -956.73 -944.16 
LRT N/A N/A X2=3.9, p<0.05 X2=2.0, p>0.10 
Abbreviations: HGS= Handgrip strength; 5M= Five meter timed walk; LOS=Length of Stay; Adm. Cat.=Admission Category; Cardio= Cardiovascular; 




Table 8- Sensitivity and Specificity Analysis of HGS Cut Points 
 LOS >/= 7 days LOS >/= 13 days Proportion 
Screened Frail HGS 
cut-
points  
SE SP AUC SE SP AUC 
Giulani 
(<14kg) 










0.84 0.25 0.56 0.87 0.23 0.55 80.35% 
 (499/621)  
Alley- Men 
(<26 kg) 







































Table 9- Sensitivity and Specificity Analysis of 5M Cut Points 
 LOS >/= 7 days LOS >/= 13 days Proportion 
Screened Frail 5m cut-
points  




















































Chapter 6: Predictive Validity of Frailty Indicators in Acute Care with Respect to QOL 
6.1 Introduction 
Patient reported outcomes are becoming of greater importance to researchers and 
stakeholders as health care philosophies shift to become more patient-centered (Desphande et al., 
2011). Quality of life (QOL) is an important patient reported outcome in acute care, as it reflects 
a patient’s overall physical, mental and social wellbeing (WHO, 1997 page 1). Research has 
shown that reduced health related quality of life is significantly associated with mortality 
(Brown, D. S., Thompson, W. W., Zack, M. M., Arnold, S. E., & Barile, J. P., 2015). 
Consequently, knowledge of what contributes to patients’ self-perceived QOL in acute care and 
after discharge is essential for developing and improving health care interventions. 
In order to ensure that QOL is not reduced as a result of hospitalization, it is important to 
determine if health care factors are associated with decreased QOL. More importantly, predicting 
or anticipating decreased QOL throughout hospital admission can help guide interventions that 
target key risk factors and support transition back to the community. Many researchers have 
attempted to determine predictors of quality of life in health care/acute care contexts. Examples 
of factors associated with QOL include: motor dysfunction, communication problems between 
patient/physician, depressive symptoms, pain, age, hemiplegia, socioeconomic status, 
psychological problems, the presence of a feeding tube, and physical functioning (Beck et al., 
2001; Engel et al., 2003; Grady et al., 1999; Paul et al., 2005; Terrell et al., 2004; Tripp et al., 
2004). Furthermore, research has been conducted to investigate predictors of QOL post-
discharge from hospital. Examples of these predictors include: health competence, mood state, 
environmental factors, mobility, social integration, access to meaningful activities, 
socioeconomic factors, and stress levels among others (Erosa et al., 2014; Grady et al., 2003; 




medical condition being investigated. Recent literature has highlighted frailty as a syndrome that 
is predictive of negative outcomes such as mortality, functional decline and hospitalization (Rijk 
et al., 2016, Stessman et al., 2017). However, current research has yet to explore frailty 
indicators specifically as potential predictors of QOL for acute care patients during 
hospitalization and post-discharge as they transition back to the community.  
This study aims to address these areas of the literature on QOL that have been neglected.  
Specifically, the predictive validity of frailty measures for self-reported QOL during 
hospitalization and 30-days post-discharge will be examined. The following research question 
will be answered: Do frailty indicators, and specifically handgrip strength or 5 meter walk (HGS 
and 5m), add predictive value when adjusting for relevant covariates to QOL during 
hospitalization and 30-days post-discharge for patients discharged to the community?  This 
research will offer a better understanding of the relationship between frailty and QOL for acute 
care patients. 
6.2 Methods 
6.2.1 Sample and Participants  
More-2-Eat was a multisite participatory action research study with a before-after time 
series design.  The primary objective of the study was to implement and evaluate the Integrated 
Nutrition Pathway for Acute Care (INPAC) in 5 Canadian hospitals. Each site was led by an 
interdisciplinary team that offered coaching and improvement strategies towards implementing 
best practices for nutrition care. The study population recruited were all patients on the chosen 
medical unit participating in this implementation study: Royal Alexandra Hospital (Edmonton, 
AB), Pasqua Hospital (Regina, SK), Concordia Hospital (Winnipeg, MB), Niagara Health 




collection at the patient level; an audit of nutrition care practices for all patients on the unit 
during audit days and a detailed assessment of nutrition, frailty, disability, quality of life and 
food intake on a subset of patients recruited each month. This latter group will be used in this 
secondary data analysis. There were 1250 patients recruited for this detailed data collection over 
a 15-month period with 278 having 30-day post-discharge data; these samples are used to 
determine the predictive validity of frailty indicators for QOL. This sample was younger (68 
years vs. 73 years; t=9.96, p<0.0001; 95% CI 3.99,5.88) than the INPAC audit data collection, 
indicating that this sample is slightly younger than medical patients on these 5 hospital units. The 
eligibility criteria as described below explain these differences in demographics.  
The eligibility criteria for the detailed patient collection were as follows: 1) no cognitive 
impairment as per admission assessment by nursing; 2) spoke English (or French at Ottawa site); 
3) consumed an oral diet, however supplemental enteral or parenteral were allowed; 4) were 
likely to return home to the community; and 5) must have provided written consent to 
participate. It should be noted that these eligibility criteria were for the primary More-2-Eat 
study, and not this secondary data analysis. The sampling design was single stage and 
participants were chosen through a quasi-random sampling process. Site researchers were 
instructed to identify which patients were eligible to participate in the study, and then starting at 
one end of the unit (first room, first bed), recruit patients until they had met their quota. In the 
baseline phase (4 weeks), 10 patients per week was the target, whereas in the implementation 
phase the quota was 20 patients per month for 12 months. For the following week/month of 
collection, site researchers were instructed to start at the bed number in which they last stopped. 




were recruited to provide diversity on QOL and frailty indicators, as well as other outcome 
measures included in the main study. 
6.2.2 Data Collection and Measures  
Clinical dietitians were seconded from their regular duties at the hospital to complete all 
data collection. Training for these research dietitians was in-person and a detailed manual was 
provided to support consistency in procedures. Monthly phone call meetings supported 
consistency in data collection and a virtual group via the Internet helped to address questions 
among these research staff. Site researchers approached a patient for informed consent, shortly 
after they were admitted and determined to be eligible. On units where they were considered part 
of the ‘circle of care’ they were allowed to directly recruit patients; where the dietitian was solely 
seconded for the research and not practicing on the unit, nursing staff determined eligibility and 
did the initial approach as per the ethics protocol to determine if the patient was interested in 
participating in the study. Final recruitment and written consent were completed by these 
research dietitians. 
 All relevant data used in this analysis were collected shortly after admission and 
typically on the same day as recruitment and included: handgrip strength (HGS), five meter 
timed walk (5m), and self-reported QOL (SF-12). To measure HGS, the research dietitians were 
trained on the Southampton protocol for HGS using a hydraulic hand dynamometer J000105 
(Roberts et al., 2011). This protocol involves patients being seated in a chair with back support 
and arms (Roberts et al., 2011). However, if patients were not able to transfer from their bed to a 
chair, the measurement was taken in bed (Keller, 2015). The research dietitian demonstrated how 
to use the hand dynamometer and explained that tightly gripping the handle gives the highest 




where an intravenous line was present in that arm, patients could use the opposite arm instead 
(Keller, 2015). All values were recorded (in kg), including the hand in which the test was 
performed. 
The 5m assessment was performed in an unobstructed, well-lit, predetermined area of the 
hospital, where patients were asked to walk at a comfortable pace between a 0m and 5m marker 
on the floor (Afilalo et al., 2010). Once the assessor said ‘go’, the timer was started with the first 
footfall over the 0m line, and the timer was stopped with the first footfall over the 5m line 
(Afilalo et al., 2010). If the patient was able, the assessment was repeated three times, with a rest 
period provided between trials to allow the patient to recuperate (Keller, 2015). The time was 
recorded in seconds. At one site, this measure was completed by the physiotherapy team on the 
unit. For both HGS and 5m, if patients were unable to complete the assessment, the reason for 
non-completion (non-ambulatory/cannot transfer, too weak, other) was also recorded (Keller, 
2015).  
Quality of life was collected via in-person interviews on the day of recruitment in the 
hospital and for a subset, 30-days post-discharge via follow-up phone calls completed by trained 
researchers at the University of Waterloo. Participants for 30-day follow-up were only recruited 
at baseline, at approximately 4-5 month, and the 11-12 month time points during implementation 
with a goal of 40 patients at each site being recruited. Quality of life was measured using the SF-
12 questionnaire, and trained researchers asked questions as they were written in the 
questionnaire.  Questions on the SF-12 reflect self-perceived health and well-being, via questions 
such as “In general, would you say your health is: Excellent, very good, good, fair or poor?” 
(Ware et al., 1995). Scoring of the SF-12 derives a physical and mental summary score, both of 




tools exist to measure quality of life, the SF-12 general health survey is a leading measure for 
acute care patients (Hamoen, 2015; Ware et al., 1995). This questionnaire focuses on both 
physical and emotional wellbeing and is relatively concise. A recent review suggested that, “the 
SF-12 be used for screening populations for QOL as it received positive ratings for criterion 
validity, construct validity, reproducibility, and interpretability. Moreover, it is a relatively short 
questionnaire, which makes it suitable for all patients” (Hamoen et al., 2015 p. 25). 
The covariates to be included in models for QOL included: site, age and sex, diagnosis 
(from health record, 7 categories), nutritional status determined via the subjective global 
assessment (SGA) (Detsky et al., 1987), education and living situation. Nutritional status via 
SGA was assessed after a patient had been screened ‘at risk’ based on the Canadian Nutrition 
Screening Tool (CNST) (Laporte et al., 2015). The SGA includes information on dietary intake, 
weight, symptoms, functional capacity and metabolic requirements, as well as a physical exam 
assessing adequacy of fat and muscle tissues and presence of edema. Patients were classified as 
either well nourished (A), mildly/moderately or suspected of being malnourished (B), or severely 
malnourished (C) (Detsky et al., 1987). Those patients identified to be ‘not at risk’ as per the 
CNST and thus not assessed by the SGA for a malnutrition diagnosis, were coded as ‘well 
nourished’ for this analysis.  
University of Waterloo (ORE #20590) and site ethics boards: Niagara Health Ethics 
Board (2015-07-001), Ottawa Health Science Network Research Ethics Board (20150345-01H), 
Health Research Ethics Board of the University of Alberta (Pro00056577), Regina Qu’Appelle 
Health Region Research Ethics Board (REB-15-68), University of Manitoba Health Research 




(H2015:208), approved and provided clearance for this research study. Data collection directly 
from patients required informed written consent, which was attained prior to data collection. 
6.2.3 Data Analysis   
A secondary data analysis was performed using SAS Studio 9.4 for Windows. 
Descriptive (mean, SD) statistics were completed and associations among patient characteristics 
and frailty and QOL were determined with t-test, ANOVA and Spearman’s rho. To determine 
whether frailty indicators (HGS and 5m) added significant predictive validity with respect to 
predicting QOL during hospitalization and 30-days post-discharge (30DQOL), multiple linear 
regression analyses were performed, adjusting for relevant covariates. Separate models were 
derived for each frailty indicator (HGS and 5m) and each outcome variable (QOL and 
30DQOL). Separate models were derived for each summary SF12 score of physical (PCS) and 
mental (MCS) QOL. Covariates in this analysis included: site, age, sex, nutritional status, 
admission diagnosis category, education and living situation. Nutritional status was categorized 
into well-nourished and malnourished, with SGA categories B and C were amalgamated as a 
‘malnourished’ group. QOL/30DQOL- the dependent variable- and HGS/5m- the independent 
variables- were continuous and were used in a numerical manner for this analysis.  All relevant 
covariates were first added to the model for the dependent variable QOL/30DQOL. Preliminary 
results showed a sex interaction, so multivariate models were stratified by sex.  Some variables 
were significant in the initial model, while other variables were added despite their significance, 
due to theoretical relevance to QOL. Next, the frailty indicator, either HGS or 5m, was added to 
this initial model to determine if the indicator added any predictive value.  The assumptions of 




used to determine statistical significance of covariates.  To determine if frailty indicators added 
anything to the models, likelihood ratio tests (LRT) were derived for each model were compared.  
6.3 Results 
The final sample included 1250 from 5 sites; 45% were male, and 55% female and the 
average age was 68.5 years (SD=15.28). The mean LOS was 12.7 days (SD=13.20), and 30% of 
patients had longer than average (13+ days) LOS for this sample (Table 1). Based on an age-
adjusted average LOS of 7 days indicated in current literature (CIHI, 2014), 54% of this sample 
had longer than this average LOS. Almost all (92%) of the sample completed the HGS 
assessment (n=1146/1250), and 43% (n=535/1250) of patients were able to complete the 5m 
assessment. QOL in hospital (PSC1/MCS1) were collected on 1247 patients (3 missing data 
entries), whereas 30-day follow-up quality of life (PSC2/MCS2) was assessed on a subset of 278 
patients. The average quality of life scores were as follows: in hospital PCS1: 34.64, MCS1: 
46.46; post discharge PCS2: 36.20; MCS2: 51.23; thus the subset with 30-day follow up had 
similar physical but higher mental QOL scores as compared to the sample in hospital.  
Tables 10 summarizes the correlation results between covariates, HGS, 5m and QOL. 
HGS and 5m were significantly associated with PCS1 (rho=0.23, p<0.0001; rho=-0.21, p<0.0001 
respectively) and PCS2 (rho=0.26, p<0.0001; rho=-0.21 p<0.05 respectively), in the anticipated 
direction, but not with the mental summary scores (MCS1/MCS2). Those who were considered 
well-nourished in hospital had significantly higher PCS1 (t=4.42, p<0.0001) and MCS1 (t=4.17, 
p<0.0001) scores than those who were considered malnourished. In addition, QOL in hospital 
(PCS1 and MCS1) was significantly different across admission diagnosis categories (F=10.37, 
p<0.0001; F=5.43, p<0.0001); those with musculoskeletal diagnoses had the lowest mean PCS1 




(44.24). Age, site, sex, education and living situation were considered theoretically relevant, and 
therefore added to the models regardless of lack statistically significant association with QOL.  
To determine the predictive validity of HGS and 5m with respect to QOL/30DQOL, all 
associated variables except for HGS/5m were included in an initial model (model 1), and then a 
second model (model 2) was created including HGS/5m. Likelihood ratio tests indicated that 
HGS added significant predictive value with respect to PCS1 for both the male sex-stratified 
model (X2= 31.78, p<0.01) and the female sex-stratified model (X2= 21.02. p<0.01) (Table 11), 
while it only added significant predictive value for MCS1 for the female sex-stratified model 
(X2=4.02, p<0.05) (Table 12). 5m also added significant predictive value for PCS1 for both the 
male sex-stratified model (X2=9.42, p<0.01) and the female sex-stratified model (X2= 15.72, 
p<0.01) (Table 13), but only added predictive value with respect to MCS1 for the male sex-
stratified model (X2=4.36, p<0.05) (Table 14). HGS also added significant predictive value to 
PCS2 for the male sex-stratified model (X2=10.62, p<0.01) and the female sex-stratified model 
(X2=10.75, p<0.01) (Table 15), but only added significant predictive value for MCS2 for the 
male sex-stratified model (X2=4.00, p<0.05) (Table 16). 5m added significant predictive value 
with respect to PCS2 for the female sex-stratified model only (X2=4.38, p<0.05) (Table 17), and 
not with respect to MCS2 (Table 18).  In essence, final models indicate the additional predictive 
value of HGS and 5m for PCS1/MCS1/PCS2/MCS2 when adjusted for these meaningful 
covariates. As noted in these final models, the addition of HGS (including other variants as 
discussed in methods) as an indicator of frailty significantly improved the predictive value of 
both the male and female models with respect to the physical component of QOL in hospital 
(PCS1) and post-discharge (PCS2), whereas 5m added significant predictive value across sexes 




should be noted that R2 values increased after the addition of the frailty indicator variable, which 
should be expected. Neither frailty indicator was adequate for predicting the mental component 
of QOL in hospital or post-discharge across both sexes, as expected given the correlation results.  
6.4 Discussion 
Research has indicated that screening for frailty needs to occur in hospital settings, 
especially among older adults (>70 years) (Morley et al., 2016). In order to do this, simple, 
objective tools are required as objective, physical performance measures, which are more 
focused on the functioning of the individual, are preferable to subjective evaluations for 
measuring frailty, especially in a clinical or hospital setting (Cesari et al., 2016). These tools also 
need to be relevant for predicting important outcomes and support clinical decision-making.  
 Correlations between HGS/5m and physical components of QOL were significant and in 
the anticipated direction, confirming that lower HGS values and longer 5m walk times are 
associated with poorer physical QOL. However, these frailty indicators do not appear to be 
consistently associated with the mental summary scores generated by the SF-12 for either sex. 
5m could only be completed on a subset of participants and there was a less consistent 
association between PCS during and post-hospitalization. The small sample size of those who 
completed the 5m and also included in the 30-day follow-up assessment of QOL likely 
contributed to the weaker association seen between 5m and PCS2 among both sexes. Based on 
this analysis, HGS appears to be a superior tool as compared to 5m for measuring frailty and 
predicting clinical outcomes such as QOL in this setting, and as noted in this sample can be 
completed by almost all cognitively well patients. Despite the correlation with physical QOL, an 
association is not sufficient to demonstrate the relevance of a new tool in clinical practice. The 




value to treatment decisions and is associated with patient outcomes, and is also responsive to 
treatment.  It is recommended that further predictive validity of these tools be assessed for other 
clinical outcomes as well as clinical treatment in a more representative sample to determine their 
utility while adjusting for other relevant covariates (e.g. disease severity) that likely influence 
these outcomes and treatment decisions. Research that demonstrates the responsiveness of HGS 
to treatment during a relatively short time frame of a hospitalization is also required.   
This analysis also warrants further exploration of whether or not HGS is truly measuring 
the entire construct of frailty. Construct validity testing needs to be done in further research to 
determine the validity of HGS as a frailty indicator. The Clinical Frailty Scale (CFS) is a 
subjective tool that has been shown to be effective and valid for measuring frailty, and provides 
important predictive information about death, and other adverse outcomes (Rockwood et al., 
2005). The Frailty Assessment for Care-planning Tool (FACT) is a modification of the CFS that 
can be used by non-experts/non-geriatricians and has been shown to be more closely associated 
the Frailty Index (Fried, 2001) than the CFS.  FACT includes validated screening tools for 
cognitive assessment, relies on collateral history instead of self-report, and combines some 
variables for easier scoring without losing information pertinent to clinical decision making 
(Moorehouse et al., 2017 not published). Both the CFS and FACT tools may be a starting point 
to determine the construct validity of single objective indicators of frailty such as HGS. 
6.5 Limitations 
A limitation of this study is the eligibility criteria for recruitment of patients, as the 
resulting sample was not representative of all medical patients on this unit when compared to 
other data collected in the M2E study.  The sample used in these analyses tended to be slightly 




and frailty characteristics as well. However, researchers were informed on the importance of 
recruiting less well and frail older adults, as they are often underrepresented in research and the 
average age is consistent with prior work on medical patients (Bowles et al., 2014; Buendgens et 
al., 2014; Donzé, Bates & Schnipper 2013). Busyness of the unit and reluctance of staff to recruit 
unwell patients may have also biased this sample. As noted in our comparisons to INPAC audit 
data, this sub-sample was slightly younger. The 30 day follow-up sample are likely 
unrepresentative as the participation rate for these calls was 53%. As well, researchers at the 
university completed these telephone calls and were potentially less expert than site researchers 
who completed more SF-12 assessments. Other limitations include the potential for inter-rater 
differences when assessing HGS and 5m and QOL post-discharge from hospital and 
measurement error.  For example, some researchers may be more diligent or motivating when 
encouraging patients to perform the assessment, resulting in superior scores. Another limitation 
to consider includes the protocol used for completion of HGS, which had to be adapted for an 
unknown proportion of patients who were in bed. Many protocols for assessing HGS exist, but 
none specific to the bedridden patient. Additionally, the succinctness of the SF-12 questionnaire 
does not give insight into all dimensions of quality of life as it focuses solely on physical and 
emotional well-being. Finally, other potential predictors of quality of life were not collected for 
M2E, as this was not the primary purpose of the study. Therefore, they cannot be controlled for 
in this secondary data analysis.  
6.6 Conclusion 
This study offers an enhanced understanding of the relationship between frailty and QOL 
in acute care patients. HGS appears to add significant additional predictive value with respect to 




an appropriate tool to use for both male and female acute care patients.  Although similar results 
were found 5m, it was less feasible for patients to complete. Future work on HGS as a measure 
to conduct with nutritional screening or malnutrition assessment should be done to describe 
potential comorbidity with frailty, which often overlaps with malnutrition (Laur et al., 2017). 
Frailty assessment should be completed in all health care sectors and the results of this study 
indicate growing confidence in the use of HGS to be an objective indicator for predicting QOL. 
Given the growing population of older adults, their susceptibility to frailty, and their health care 
utilization, it is critical that further research be conducted on HGS as a potential frailty measure 
for the clinical setting to support clinical decision making and course of treatment, as it appears 






























Table 10- Descriptive Statistics and Correlations with QOL 
 
Test statistic: * p<.05  **p<.01 ***p<0.001 
1Malnourished group includes: SGA Bs and Cs; 2Well-nourished group includes: No risk and SGA A 
Abbreviations: HGS= Handgrip strength; 5M= Five meter timed walk; PCS1=Physical QOL in hospital; 
PCS2=Physical QOL 30 days post discharge; MCS1= Mental QOL in hospital; MCS2=Mental QOL 30 days post 
discharge; M=Male; F=Female; HS= High School








PCS1 (n=1247) 34.64 ----- ----- ----- ----- 
MCS1 (n=1247) 46.46 ----- ----- ----- ----- 
PCS2 (n=278) 36.20 ----- ----- ----- ----- 
MCS2 (n=278) 51.23 ----- ----- ----- ----- 
HGS (n=1146) 20.82 kg (12.35) 0.23*** 0.043 0.26*** 0.085 
HGS (sex stratified) M: 28.26 kg (12.45) 
F: 14.54 kg (8.01) 
    
5m (n=535) Median= 8.98 s (6.59) -0.21*** -0.038 -0.21* -0.059 
5m (sex stratified) M: median=7.80 s (5.70) 
F: median=10.27 s (7.24) 
    
Age (n=1250) 68.48 years (15.28) 0.019 0.14*** -0.14* 0.23*** 
Age (sex stratified) M: 66.91 years (15.09) 
F: 69.76 years (15.32) 
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Table 11- Regression Analysis of In Hospital Physical QOL (PCS1) and HGS Stratified by Sex 
 Model 1 Model 2 
Male (n=525) Female (n=621) Male (n=525) Female (n=621) 
Parameter estimate  
(95% CI) 
P value Parameter estimate  
(95% CI) 
P value Parameter estimate  
(95% CI)  
P value Parameter estimate  
(95% CI) 
P value 
HGS N/A N/A N/A N/A 0.23 (0.1, 0.3) <.0001 0.28 (0.2, 0.4) <.0001 








1.60 (-1.6, 4.8) 
-0.79 (-3.9, 2.4) 
0.55 (-2.3, 3.4) 
2.59 (-0.7, 5.9) 
----- 
0.32  
5.24 (2.2, 8.2) 
1.86 (-0.8, 4.5) 
1.45 (-1.2, 4.1) 
6.30 (3.6, 9.0) 
----- 
<.0001  
2.64 (-0.5, 5.8) 
2.08 (-1.1, 5.3) 
0.96 (-1.8, 3.8) 
3.67 (0.4, 6.9) 
----- 
0.16  
6.03 (3.1, 9.0) 
5.52 (2.5, 8.6) 
2.07 (-0.6, 4.7) 








-3.30 (-5.6, -1.0) 
0.005  
----- 
-1.92 (-3.9, 0.03) 
0.05  
----- 
-2.18 (-4.5, 0.1) 
0.06  
----- 













-3.01 (-7.2, 1.2) 
-2.10 (-5.5, 1.3) 
-4.75 (-9.2, -0.3) 
1.62 (-2.2, 5.4) 
-3.54 (-7.1, 0.1) 
-1.0 (-4.3, 2.3) 
0.07  
----- 
1.75 (-1.8, 5.3) 
0.16 (-2.7, 3.0) 
-3.50 (-6.8, -0.2) 
3.57 (0.07, 7.1) 
-1.94 (5.2, 1.3) 
-0.15 (-3.0, 2.7) 
0.005  
----- 
-2.86 (-6.9, 1.2) 
-2.42 (-5.7, 0.8) 
-5.33 (-9.7, -1.0) 
1.35 (-2.4, 5.0) 
-3.15 (-6.7, 0.3) 




1.25 (-2.2, 4.8) 
-0.14 (-3.0, 2.7) 
-3.09 (-6.3, 0.1) 
3.52 (0.1, 7.0) 
-2.13 (-5.3, 1.1) 
















1.02 (-0.9, 2.9) 
 
 





-0.69 (-2.7, 0.8) 
 
 





0.61 (-1.2, 2.4) 
 
 






-1.0 (-2.7, 0.7) 
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1.51 (-0.6, 3.6) 
 
1.47 (-1.7, 4.6) 
 
 




 0.41 (-1.5, 2.3) 
 
-1.40 (-4.5, 1.7) 
 
 




0.89 (-1.2, 3.0) 
 
0.56 (-2.5, 3.6) 
 
 




0.44 (-1.4, 2.3) 
 
-1.18 (-4.2, 1.9) 
 
 












1.20 (-5.1, 7.5) 
 
 
2.70 (-3.6, 9.0) 
 
 




3.74 (-2.4, 9.9) 
 
R2 0.081 0.118 0.135 0.147 
Log likelihood -1947.25 -2271.20 -1931.36 -2260.69 
LRT N/A N/A X2= 31.78, p<0.01 X2=21.02, p<0.01 
Abbreviations: HGS= Handgrip strength; QOL: Quality of life; PCS1=Physical QOL in hospital Adm.Cat.= Admission Category; Cardio.= Cardiovascular; Gastro.= 




























Table 12- Regression Analysis of In Hospital Mental QOL (MCS1) and HGS Stratified by Sex 
 Model 1 Model 2 
Male (n=525) Female (n=621) Male (n=525) Female (n=621) 
Parameter estimate 
 (95% CI) 
P value Parameter estimate 
 (95% CI)  
P value Parameter estimate 
(95% CI)   
P value Parameter estimate 
 (95% CI)  
P value 
HGS N/A N/A N/A N/A 0.03 (-0.06, 0.1) 0.52 0.14 (0.001, 0.3) 0.05 








-2.24 (-5.8, 1.3) 
1.10 (-2.4, 4.6) 
2.88 (-0.3, 6.1) 




-3.92 (-7.4, -0.4) 
0.18 (-2.9, 3.3) 
0.27 (-2.8, 3.4) 
-1.34 (-4.5, 1.8) 
----- 
0.07  
-2.10 (-5.7, 1.5) 
1.48 (-2.2, 5.2) 
2.93 (-0.3, 6.1) 
5.27 (1.6, 9.0) 
----- 
0.003  
-3.51 (-7.0, -0.01) 
2.07 (-1.5, 5.7) 
0.59 (-2.5, 3.7) 











-3.40 (-5.7, -1.1) 
0.004  
----- 
-2.90 (-5.5, -0.3) 
0.03  
----- 













-0.59 (-5.2, 4.1) 
0.80 (-2.9, 4.5) 
2.07 (-2.9, 7.0) 
0.01 (-4.2, 4.2) 
0.11 (-3.9, 4.1) 




0.55 (-3.6, 4.7) 
-2.10 (-5.5, 1.3) 
0.73 (-3.1, 4.5) 
0.77 (-3.3, 4.8) 
1.23 (-2.7, 4.9) 
-1.02 (-4.4, 2.3) 
0.43  
----- 
-0.57 (-5.2, 4.1) 
0.76 (-3.0, 4.5) 
2.00 (-3.0, 6.9) 
-0.03 (-4.2, 4.2) 
0.16 (-3.8, 4.1) 
-1.81 (-5.5, 1.9) 
0.69  
----- 
0.30 (-3.8, 4.4) 
-2.26 (-5.6, 1.1) 
0.94 (-2.9, 4.7) 
0.75 (-3.3, 4.8) 
1.02 (-2.8, 4.8) 















-1.94 (-3.3, 0.9) 
 
 





1.38  (-0.6, 3.4) 
 
 





-1.25 (-3.3, 0.8) 
 
 





1.37 (-0.6, 3.4) 
 
 






















3.14 (0.8, 5.5) 
 





1.68 (-0.5, 3.9) 
 





3.06 (0.7, 5.4) 
 





1.69 (-0.5, 3.9) 
 





W/ Spouse & 
other family  
 







2.77 (-0.4, 5.9) 
 
 
-1.38 (-8.3, 5.6) 
 
 
0.60 (-1.8, 3.0) 
 
 
0.01 (-7.3, 7.3) 
 
 
2.83 (-0.3, 6.0) 
 
 
-1.26 (-8.2, 5.7) 
 
 
0.72 (-1.7, 3.2) 
 
 
0.54 (-6.7, 7.8) 
R2 0.106 0.105 0.106 0.110 
Log likelihood -2000.23 -2365.90 -2000.01 -2363.89 
LRT N/A N/A X2= 0.44, 0.50<p<0.75 X2=4.02, p<0.05 
Abbreviations: HGS= Handgrip strength; QOL: Quality of life; MCS1=Mental QOL in hospital Adm.Cat.= Admission Category; Cardio.= Cardiovascular; Gastro.= 


























Table 13- Regression Analysis of In Hospital Physical QOL (PCS1) and 5M Stratified by Sex 
 Model 1 Model 2 
Male (n=279) Female (n=256) Male (n=279) Female (n=256) 
Parameter estimate (95% 
CI) 
P value Parameter estimate          
(95% CI) 
P value Parameter estimate         
(95% CI) 
P value Parameter estimate        
(95% CI) 
P value 
5m N/A N/A N/A N/A -0.36 (-0.6, -0.1) 0.003 -0.36 (-0.5, -0.2) 0.0001 








3.49 (-1.4, 8.3) 
-0.15 (-5.5, 5.2) 
1.10 (-3.3, 5.5) 
5.26 (0.2, 10.4) 
----- 
0.13  
4.65 (-0.8, 10.1) 
2.47 (-2.6, 7.6) 
-0.25 (-5.0, 4.4) 
7.31 (2.4, 12.3) 
----- 
0.001  
2.56 (-2.3, 7.4) 
-0.78 (-6.0, 4.5) 
0.20 (-4.2, 4.6) 
6.35 (1.3, 11.4) 
----- 
0.03  
3.67 (-1.6, 9.0) 
0.84 (-4.2, 5.9) 
-0.44 (-5.0, 4.1) 








-6.61 (-10.2, -3.0) 
0.0004  
----- 
-2.18 (-5.5, 1.1) 
0.20  
----- 
-5.42 (-9.1, -1.8) 
0.004  
----- 













0.05 (-6.0, 6.0) 
-1.51 (-5.8, 2.8) 
-7.65 (-15.2, -0.09) 
1.59 (-3.4, 6.6) 
-2.36 (-7.4, 2.6) 
3.31 (-1.2, 7.5) 
0.06  
----- 
-0.84 (-6.1, 4.5) 
-2.52 (-7.1, 2.1) 
-5.12 (-10.7, 0.5) 
0.85 (-4.5, 6.2) 
-3.84 (-9.1, 1.4) 




-0.50 (-6.4, 5.4) 
-1.86 (-6.1, 2.4) 
-7.64 (-15.1, -0.2) 
0.58 (-4.4, 5.6) 
-2.66 (-7.6, 2.3) 
2.54 (-1.7, 6.8) 
0.09  
----- 
-0.22 (-5.4, 5.0) 
-1.92 (-6.4, 2.6) 
-1.42 (-7.2, 4.3) 
2.28 (-2.9, 7.5) 
-3.71 (-8.8, 1.4) 















2.32 (-0.5, 5.1) 
 
 





-0.53 (-3.3, 2.3) 
 
 






1.00 (-0.8, 4.7) 
 
 





-0.79 (-3.5, 1.9) 
 
 






















1.01 (-1.7, 4.2) 
 





1.03  (-1.7, 4.2) 
 





0.69 (-2.2, 3.6) 
 





1.05 (-1.9, 3.9) 
 





W/ Spouse & 
other family  
 







-3.21 (-7.5, 1.1) 
 
 




-2.79 (-6.5, 1.0) 
 
 
-2.21 (-12.4, 8.0) 
 
 
-3.37 (-7.6, 0.9) 
 
 
-7.02 (-19.2, 5.1) 
 
 
-1.50 (-5.2, 2.2) 
 
 
-2.96 (-12.9, 7.0) 
R2 0.149 0.157 0.177 0.207 
Log likelihood -1036.08 -934.36 -1031.37 -926.50 
LRT N/A N/A X2=9.42, p<0.01 X2=15.72, p<0.01 
Abbreviations: 5m= 5 meter walk test; QOL: Quality of life; PCS1=Physical QOL in hospital Adm.Cat.= Admission Category; Cardio.= Cardiovascular; Gastro.= 


























Table 14- Regression Analysis of In Hospital Mental QOL (MCS1) and 5M Stratified by Sex 
 Model 1 Model 2 
Male (n=279) Female (n=256) Male (n=279) Female (n=256) 
Parameter estimate 
(95% CI) 
P value Parameter estimate 
(95% CI) 
P value Parameter estimate (95% 
CI) 
P value Parameter estimate (95% 
CI)  
P value 
5m N/A N/A N/A N/A -0.25 (-0.5, -0.01) 0.04 -0.05 (-0.3, 0.2) 0.65 








-5.68 (-10.6, -0.8) 
-1.27 (-6.6, 4.1) 
-5.04 (-9.5,-0.5) 





-3.61 (-9.7, 2.5) 
-1.57 (-7.3, 4.1) 
-1.04 (-6.3, 4.2) 
-2.46 (-8.0, 3.1) 
----- 
0.74  
-6.33 (-11.3, -1.4) 
-1.71 (-7.1, 3.6) 
-5.67 (-10.2, -1.2) 
-2.77 (-7.9, 2.4) 
----- 
0.06  
-3.75 (-9.9, 2.4) 
-1.79 (-7.6, 4.0) 
-1.07 (-6.3, 4.2) 








-2.49 (-6.1, 1.2) 
0.18  
----- 
-3.87 (-7.6, -0.2) 
0.04  
----- 
-1.67 (-5.4, 2.0) 
0.38  
----- 













-0.82 (-6.9, 5.3) 
-1.15 (-5.5, 3.2) 
1.36 (-6.3, 9.0) 
-0.89 (-6.0, 4.2) 
-2.40 (-7.5, 2.7) 




-3.76 (-9.7, 2.1) 
-0.79 (-5.9, 4.4) 
0.15 (-6.1, 6.4) 
-2.17 (-8.1, 3.8) 
3.93 (-1.9, 9.8) 
-1.75 (-6.9, 3.4) 
0.31  
----- 
-1.21 (-7.3, 4.9) 
-1.39 (-5.7, 3.0) 
1.36 (-6.2, 9.0) 
-1.59 (-6.7, 3.5) 
-2.61 (-7.7, 2.4) 
-4.97 (-9.3, -0.6) 
0.33  
----- 
-3.67 (-9.6, 2.4) 
-0.71 (-5.9, 4.5) 
0.64 (-6.0, 7.3) 
-1.97 (-8.0, 4.0) 
3.95 (-1.9, 9.8) 




































































W/ Spouse & 
other family  
 









2.96 (-0.03, 5.9) 
 
 
-3.19 (-7.7, 1.3) 
 
 
0.53 (-3.8, 4.9) 
 
 





2.12 (-1.2, 5.4) 
 
 
1.93 (-3.7, 7.6) 
 
 
0.39 (-3.8, 4.6) 
 
 





2.60 (-0.4, 5.6) 
 
 
-3.15 (-7.6, 1.3) 
 
 
0.42 (-3.9, 4.7) 
 
 





2.08 (-1.2, 5.4) 
 
 
1.86 (-3.8, 7.5) 
 
 
 0.57 (-3.7, 4.8) 
 
 
1.50 (-9.9, 12.9) 
0.79 
R2 0.164 0.124 0.177 0.124 
Log likelihood -1039.55 -962.6201 -1037.37 -962.51 
LRT N/A N/A X2=4.36, p<0.05 X2=0.22, 0.50<p<0.75 
Abbreviations: 5m= 5 meter walk test; QOL: Quality of life; MCS1=Mental QOL in hospital Adm.Cat.= Admission Category; Cardio.= Cardiovascular; Gastro.= 





Table 15- Regression Analysis of 30D Physical QOL (PCS2) and HGS Stratified by Sex 
 Model 1 Model 2 





















HGS N/A N/A N/A N/A 0.35 (0.1, 0.6) 0.003 0.38 (0.1, 0.6) 0.003 








9.07 (0.3, 17.8) 
1.99 (-7.3, 11.2) 
4.55 (-3.4, 12.5) 
-1.73 (-9.5, 6.0) 
----- 
0.15  
-1.68 (-8.9, 5.5) 
-2.59 (-9.4, 4.2) 
-3.39 (-10.2, 3.4) 
-2.26 (-9.0, 4.5) 
----- 
0.90  
11.69 (3.2, 20.2) 
7.49 (-1.0, 16.1) 
8.02 (0.9, 15.2) 
1.71 (-5.2, 8.6) 
----- 
0.05  
0.27 (-6.3, 6.8) 
3.56 (-3.5, 10.6) 
-1.70 (-7.8, 4.4) 








2.07 (-4.1, 8.2) 
0.51  
----- 
-3.18 (-8.0, 1.6) 
0.19  
----- 
3.50 (-1.3, 8.8) 
0.25  
----- 













2.77 (-8.1, 13.7) 
-3.23 (-12.3, 5.9) 
-7.88 (-19.7, 3.9) 
12.11 (2.5, 21.7) 
-4.05 (-13.8, 5.8) 




3.81 (-3.4, 11.1) 
4.36 (-1.7, 10.4) 
1.02 (-6.3, 8.3) 
4.74 (-1.9, 11.4) 
2.46 (-5.3, 10.2) 
3.67 (-2.9, 10.3) 
0.77  
----- 
5.71 (-3.8, 15.2) 
-1.85 (-9.7, 6.0) 
-6.82 (-17.0, 3.3) 
12.74 (4.5, 21.0) 
-0.32 (-9.0, 8.4) 
5.74 (-1.8, 13.3) 
0.008  
----- 
3.17 (-3.3, 9.6) 
4.21 (-1.2, 9.6) 
1.43 (-5.1, 7.9) 
4.18 (-1.8, 10.1) 
0.92 (-6.1, 7.9) 





































































W/ Spouse & 













-0.56 (-6.4, 5.2) 
 
 
-0.64 (-10.5, 9.2) 
 
 
4.08 (-4.4, 12.5) 
 
 






-0.68 (-4.6, 3.0) 
 
 
-0.30 (-6.7, 6.1) 
 
 
1.76 (-3.7, 7.2) 
 
 






-1.44 (-6.4, 3.6) 
 
 
-2.31 (-10.8, 6.2) 
 
 
6.44 (-0.9, 13.8) 
 
 






-0.93 (-4.5, 2.6) 
 
 
-0.79 (-6.5, 4.9) 
 
 
1.51 (-3.1, 6.3) 
 
 
8.96 (-2.2, 20.1) 
0.48 
R2 0.238 0.088 0.307 0.152 
Log 
likelihood 
-419.47 -530.94 -414.28 -525.61 
LRT N/A N/A X2=10.62, p<0.01 X2=10.75, p<0.01 
Abbreviations: HGS= Handgrip strength; QOL: Quality of life; PCS2=Physical QOL 30 days post-discharge; 
Adm.Cat.= Admission Category; Cardio.= Cardiovascular; Gastro.= Gastrointenstinal; Resp.= Respiratory; Musc.= 






Table 16- Regression Analysis of 30D Mental QOL (MCS2) and HGS Stratified by Sex 
 Model 1 Model 2 

















HGS N/A N/A N/A N/A 0.19 (-0.006, 0.4) 0.07 -0.04 (-0.3, 0.2) 0.80 








0.47 (-7.4, 8.3) 
1.84 (--6.5, 10.2) 
-1.27 (-8.5, 5.9) 
4.86 (-2.1, 11.8) 
----- 
0.53  
0.14 (-6.9, 7.2) 
-2.57 (-9.2, 4.1) 
-4.40 (-11.0, 2.2) 
-1.94 (-8.5, 4.7) 
----- 
0.59  
1.92 (-5.1=2, 9.0) 
4.95 (-3.0, 12.9) 
0.69 (-5.9, 7.3) 
6.79 (0.4, 13.2) 
----- 
0.33  
-0.06 (-6.6, 6.5) 
-3.20 (-10.3, 3.9) 
-4.58 (-10.7, 1.6) 








-0.76 (-6.3, 4.8) 
0.79  
----- 
0.69 (-4.0, 5.4) 
0.77  
----- 
0.04 (-4.9, 5.0) 
0.99  
----- 













-0.86 (-10.7, 9.0) 
-1.73 (-9.9, 6.5) 
-3.49 (-14.1, 7.1) 
-6.50 (-15.2, 2.2) 
3.40 (-5.4, 12.2) 
-0.30 (-8.0, 7.4) 
0.51  
----- 
-3.08 (-10.1, 3.9) 
-4.24 (-10.1, 1.6) 
2.95 (-4.2, 10.1) 
-2.47 (-9.0, 4.0) 
-2.23 (-9.8, 5.3) 




0.80 (-8.0, 9.6) 
-0.95 (-8.2, 6.3) 
-2.89 (-12.3, 6.5) 
-6.14 (-13.8, 1.5) 
5.50 (-2.6, 13.6) 
1.22 (-5.8, 8.2) 
0.32  
----- 
-3.01 (-9.5, 3.5) 
-4.23 (-9.7, 1.2) 
2.91 (-3.7, 9.5) 
-2.42 (-8.4, 3.6) 
-2.10 (-9.1, 5.0) 





































































W/ Spouse & 












4.94 (-0.3, 10.2) 
 
 
-0.10 (-9.0, 8.8) 
 
 
-7.90 (-15.5, -0.3) 
 
 





-0.07 (-3.9, 3.8) 
 
 
-5.50 (-11.7, 0.7) 
 
 
-1.46 (-6.7, 3.8) 
 
 





4.44 (-0.2, 9.1) 
 
 
-1.04 (-8.9, 6.8) 
 
 
6.56 (-13.4, 0.3) 
 
 





-0.05 (-3.6, 3.5) 
 
 
-5.45 (-11.2, 0.3) 
 
 
-1.44 (-6.3, 3.4) 
 
 
6.66 (-4.6, 17.9) 
 
0.25 
R2 0.157 0.103 0.187 0.104 
Log 
likelihood 
-408.04 -526.78 -406.03 -526.73 
LRT N/A N/A X2=4.0, p<0.05 X2=0.06, 0.75<p<0.90 
Abbreviations: HGS= Handgrip strength; QOL: Quality of life; MCS2=Mental QOL 30 days post-discharge; 
Adm.Cat.= Admission Category; Cardio.= Cardiovascular; Gastro.= Gastrointenstinal; Resp.= Respiratory; Musc.= 




Table 17- Regression Analysis of 30D Physical QOL (PCS2) and 5M Stratified by Sex 
 Model 1 Model 2 
Male (n=66) Female (n=73) Male (n=66) Female (n=73) 












Parameter estimate (95% 
CI)  
P value 
5m N/A N/A N/A N/A -0.22 (-0.7, 0.3) 0.36 -0.34 (-0.7, 0.03) 0.08 








2.61 (-9.8, 15.0) 
-2.69 (-16.8, 11.4) 
-2.49 (-14.0, 9.0) 
-2.96 (-14.8, 8.9) 
----- 
0.85  
-0.11 (-11.8, 11.5) 
-0.12 (-11.4, 11.2) 
-8.10 (-18.2, 2.0) 
1.62 (-7.9, 11.1) 
----- 
0.16  
0.53 (-12.7, 13.7) 
-4.90 (-19.8, 13.7) 
-4.27 (-16.4, 7.9) 
-1.95 (-14.0, 10.1) 
----- 
0.85  
-2.64 (-14.4, 9.1) 
-3.70 (-15.5, 8.1) 
-10.24 (-20.5, -0.03) 








5.63 (-2.9, 14.1) 
0.19  
----- 
-5.50 (-13.5, 2.5) 
0.17  
----- 
6.80 (-2.1, 15.7) 
0.13  
----- 












-1.77 (-15.5, 11.9) 
-1.37 (-12.6, 9.8) 
-7.64 (-26.1, 10.8) 
9.37 (-2.1, 20.8) 
-9.78 (-23.8, 4.2) 
4.85 (-4.7, 14.4) 
0.11  
----- 
0.36 (-10.5, 11.2) 
-3.39 (-13.8, 7.0) 
-1.42 (-17.6, 14.8) 
-0.97 (-11.1, 9.1) 
4.50 (-6.9, 15.9) 
-1.88 (-12.1, 8.4) 
0.94  
----- 
-1.04 (-14.9, 12.8) 
-1.59 (-12.8, 9.6) 
-6.03 (-24.8, 12.8) 
7.04 (-5.5, 19.6) 
-10.35 (-24.5, 3.8) 
4.35 (-5.3, 14.0) 
0.27  
----- 
-0.75 (-11.4, 9.9) 
-4.26 (-14.5, 6.0) 
-0.88  (-16.8, 15.0) 
-1.49 (-11.4, 8.4) 
3.13 ( -8.1, 14.4) 





































































W/ Spouse & 
other family  
 









1.37 (-5.9, 8.7) 
 
2.40 (-10.6, 15.4) 
 
 
0.23 (-9.7, 16.5) 
 
 






-1.75 (-7.9, 4.4) 
 
2.92 (-7.1, 12.9) 
 
 
-1.36 (-9.5, 6.8) 
 
 





0.65 (-6.8, 8.1) 
 
2.50 (-10.5, 15.5) 
 
 
0.23 (-9.7, 16.6) 
 
 





-1.93 (-7.9, 4.1) 
 
0.68 (-9.5, 10.8) 
 
 
-0.74 (-8.8, 7.3) 
 
 
2.23 (-15.1, 19.6) 
 
0.95 
R2 0.308 0.210 0.321 0.256 
Log likelihood -239.48 -259.42 -238.87 -257.23 
LRT N/A N/A X2=1.22, 0.25<p<0.50 X2=4.38, p<0.05 
Abbreviations: 5m= 5 meter walk test; QOL: Quality of life; PCS2=Physical QOL 30 days post-discharge; Adm.Cat.= Admission Category; Cardio.= Cardiovascular; Gastro.= 





















Table 18- Regression Analysis of 30D Mental QOL (MCS2) and 5M Stratified by Sex 
 Model 1 Model 2 
Male (n=66) Female (n=73) Male (n=66) Female (n=73) 




Parameter estimate (95% 
CI) 
P value Parameter estimate (95% 
CI)   
P 
value 
Parameter estimate (95% 
CI) 
P value 
5m N/A N/A N/A N/A -0.34 (-0.8, 0.2) 0.18 0.09 (-0.3, 0.4) 0.63 








0.40 (-12.4, 13.2) 
0.24 (-14.4, 14.9) 
-4.77 (-16.7, 7.1) 
0.44 (-11.8, 12.7) 
----- 
0.80  
-3.40 (-14.2, 7.4) 
-1.74 (-12.3, 8.8) 
-2.72 (-12.1, 6.7) 
-2.36 (-11.2, 6.5) 
----- 
0.97  
-2.77 (-16.3, 10.8) 
-3.12 (-18.5, 12.2) 
-7.48 (-19.9, 5.0) 
1.98 (-10.4, 14.3) 
----- 
0.58  
-2.76 (-14.0, 8.5) 
-0.84 (-12.1, 10.4) 
-2.17 (-11.9, 7.6) 








-1.30 (-10.1, 7.5) 
  
----- 
4.51 (-2.9, 11.9) 
  
----- 
0.48 (-8.7, 9.6) 
  
----- 













-2.98 (-17.2, 11.2) 
-3.39 (-15.0, 8.2) 
-3.42 (-22.6, 15.7) 
-0.90 (-12.8, 11.0) 
7.10 (-7.44, 21.6) 
1.05 (-8.9, 10.9) 
0.87  
----- 
-5.29 (-15.3, 4.7) 
-1.01 (-10.7, 8.6) 
-2.15 (-17.2, 12.9) 
-4.55 (-13.9, 4.8) 
-2.76 (-13.3, 7.8) 
-0.11 (-9.6, 9.4) 
0.90  
----- 
-1.87 (-16.0, 12.3) 
-3.73 (-15.3, 7.8) 
-0.96 (-20.3, 18.4) 
-4.43 (-17.3, 8.4) 
6.22 (-8.3, 20.7) 
0.28 (-9.6, 10.2) 
0.84  
----- 
-5.01 (-15.2, 5.2) 
-0.79 (-10.5, 9.0) 
-2.28 (-17.5, 12.9) 
-4.42 (-13.9, 5.1) 
-2.42 (-13.2, 8.3) 




































































W/ Spouse & 
other family  
 









6.22 (-1.4, 13.8) 
 
 
1.29 (-12.2, 14.8) 
 
 
-13.47 (-27.1, 0.1) 
 
 





1.90 (-3.8, 7.6) 
 
 
-1.93 (-11.2, 7.4) 
 
 
-5.07 (-12.7, 2.5) 
 
 





5.13 (-2.6, 12.8) 
 
 
1.44 (-11.9, 14.8) 
 
 
-13.46 (-17.0, 0.04) 
 
 





1.95 (-3.8, 7.7) 
 
 
-1.36 (-11.0, 8.3) 
 
 
-5.23 (-12.9, 2.5) 
 
 
10.29 (-6.3, 26.9) 
0.24 
R2 0.249 0.216 0.279 0.219 
Log likelihood -241.91 -254.04 -240.59 -253.88 
LRT N/A N/A X2=2.64, 0.10<p<0.25 X2=0.32, 0.50<p<0.75 
Abbreviations: 5m= 5 meter walk test; QOL: Quality of life; MCS2=Mental QOL 30 days post-discharge; Adm.Cat.= Admission Category; Cardio.= Cardiovascular; Gastro.= 




Chapter 7: Discussion 
 
7.1 Introduction 
The purpose of this research was to help create a better understanding of how frailty can 
be identified in an acute care setting with single indicators and whether these indicators 
(HGS/5m) could be used to predict important health outcomes. More specifically, the first goal 
of this research was to gain a better understanding of the feasibility of two objective frailty 
indicators to ultimately promote the use of the most appropriate tools in acute care. Another 
important goal of this research was to determine the predictive value of these tools to make 
important clinical decisions around treatment to promote best care practices with respect to LOS 
and QOL. Understanding what is associated with the construct of frailty in the acute care 
context, how it can feasibly be identified in this setting and how frailty is implicated in LOS and 
QOL had not yet been established in current literature. It is known that LOS is an important 
health outcome, and shorter LOS will improve patient flow and health care costs. Thus, 
identifying individuals who may have extended LOS using a simple indicator of frailty may 
support earlier treatment and thus potentially earlier discharge.  In addition, current predictors of 
QOL for acute care patients are limited in research, and specifically single measures of frailty 
have yet to be investigated as potential predictors.  This research aimed to strengthen the 
literature in this field and help to solve some of these existing gaps. 
7.2 Feasibility of single indicators (HGS and 5m)  
Experts have indicated that screening for frailty needs to occur in hospital settings, 
especially among older adults (>70 years) (Morley et al., 2016). For busy clinical environments, 
simple, objective tools are required.  Such objective, physical performance measures, which are 




measuring frailty (Cesari et al., 2016). Screening should also be a quick and simple, preferably 
using as few indicators as possible to determine the likelihood of a condition (Kondrup et al., 
2003). It has been shown that tests taken earlier or are quicker to complete produce better health 
outcomes (di Ruffano et al., 2012). Furthermore, to be of greatest utility for case finding, a 
screening tool should be completed on the entire target population, and in this case, acute care 
medical patients (Dans et al., 2011). In order to do this, the tool should ideally be able to be 
completed by any member of the medical team to avoid increasing the burden of a single 
discipline.  
Study 1 (Chapter 4) identified that the 5m is likely not a suitable measure for screening of 
frailty in acute care, as less than half of patients could complete this measurement; many patients 
felt they were too fatigued, weak, dizzy, etc. to get out of bed. In addition, the difference in 
capacity to complete the 5m by sex was significant. This reinforces the unsuitability of 5m as a 
potential screening tool, as the acute care setting requires a screening tool that can be used by all 
(Kondrup et al., 2003). Furthermore, test-treatment pathways are typically unsuccessful if 
patients are unwilling to undergo a test or procedure (di Ruffano et al., 2012). Prior research has 
shown that the 5m is in fact reliable and feasible in community-dwelling older adults 
(Tiedemann, et al. 2008), indicating the need to potentially consider different measures in 
different settings. A significantly longer LOS, and a high proportion of perceived disability was 
seen in those who could not complete the 5m, indicating that perhaps completion status of the 
5m in and of itself, rather than slow gait speed could be a helpful indicator of frailty or other 
patient reported outcomes. 
 Almost the entire sample was able to complete the HGS measure, indicating that it is 




to treatment and care activities. This tool was feasible in older adults, and had higher completion 
rates among both males and females as compared to the 5m. Another important consideration for 
determining an appropriate screening tool for frailty is the association with nutritional status. In 
addition to overall feasibility, patients were able to complete the HGS assessment, regardless of 
nutritional status. This is critical if clinicians are inclined to add SGA to a frailty indicator to 
provide a more comprehensive representation of frailty. As a result of Study 1 findings, further 
discussion will be focused on the use of HGS as a frailty measure for hospital patients.  
7.2 Is HGS a measure of frailty (and not malnutrition)?  
There was considerable overlap between nutritional status and frailty (as measured by the 
5 m), with 71% of those being malnourished, also being frail.  The significant association for 
both HGS and 5m scores with nutritional status, helps to demonstrate construct validity in these 
frailty indicators, as frailty and malnutrition are theoretically related (Clegg et al., 2013; Chung 
et al., 2014; Jeejeebhoy, 2012; Savva et al., 2012; Studenski et al., 2003). In addition, patients in 
this analysis who had lower HGS scores typically had lower perceived and actual food intake, 
and experienced more barriers to food intake.  These associations suggest that HGS may be more 
related to malnutrition than 5m, and thus it is not surprising that some have considered HGS as a 
potential indicator for malnutrition (Norman et al., 2011). Yet, this association with functional 
capacity to eat suggests that HGS is measuring risk factors for poor food intake rather than 
malnutrition per se. This evidence could be used to substantiate the view that HGS has potential 
utility for use in acute care, as it may point to an individual with barriers to food intake while in 
hospital that needs intervention. As well, HGS (using the cut-points in chapter 5) was found to be 
a poor proxy measure for malnutrition due to inadequate SE and SP when compared to the SGA 




SE=0.86, SP=0.21; Alley Male: SE=0.59, SP=0.63; Alley Female: SE=0.70, SP=0.46). These 
findings confirm Jeejeebhoy’s early findings (Jeejeebhoy et al., 2015) that HGS is measuring a 
construct that is different from but associated with malnutrition, and in this context, potentially 
frailty.  
The construct validity of these indicators was further reinforced with significant 
differences in both HGS and 5m scores in those who did not perceive any disability vs. those 
who did perceive that they had a disability. This suggests that 5m and HGS are likely measuring 
something analogous to physical frailty rather than malnutrition. Yet, this analysis also warrants 
further exploration of whether or not HGS is truly measuring the entire construct of frailty. 
Criterion validity testing needs to be done in further research to determine the validity of these 
tools for this purpose. The Clinical Frailty Scale (CFS) is a subjective tool that has been shown 
to be effective and valid for measuring frailty, and provides important predictive information 
about death, and other adverse outcomes (Rockwood et al., 2005). Current work is being done to 
improve the utility of the CFS. The Frailty Assessment for Care-planning Tool (FACT) is a 
modification of the CFS that can be used by non-experts/non-geriatricians, includes validated 
screening tools for cognitive assessment, relies on collateral history instead of self-report, and 
combines some scores for easier scoring without losing information pertinent to clinical decision 
making (Moorehouse et al., 2017 not published). This tool has been shown to be more closely 
associated the Frailty Index (Fried, 2001) than the CFS.  Both the CFS and FACT tools may be a 
starting to point to determine the criterion validity of single objective measures such as HGS by 
collecting frailty data on acute care patients from CFS, FACT and HGS and completing SE and 




7.3 Who has a low HGS and what could this mean for hospital patients?  
In this sample, those who had low HGS also experienced a variety of negative health related 
characteristics. These people tended to be malnourished, perceived that they had a disability, had 
lower levels of education, did not live with their spouse/immediate family, had low food intake 
in hospital, perceived that they were not eating enough, and had more barriers to food intake 
while in hospital. The multitude of negative health related characteristics captured in this 
analysis in association with low HGS indicates that perhaps this tool is capturing those who are 
frail as defined by Rockwood (2005), who defined frailty as an accumulation of deficits over 
time that reduces one’s capacity to resist stressors (Rockwood, 2005). These negative health 
characteristics are also related to many of the indicators used to make up the Frailty Index (from 
which the Clinical Frailty Scale was derived from) (Rockwood et al., 2005). This is also 
consistent with the Fried (2001) criteria for frailty that suggests that weight loss is a significant 
component of frailty. These associations suggest that perhaps those who have low HGS in this 
sample, are in fact those who are frail. Based on this rationale, there is great utility in finding 
those who have low HGS in clinical practice. Those who have low HGS likely need greater 
treatment with respect to nutrition care as they experience more barriers to food intake, and 
actually consume less food in hospital than those who have higher HGS. Further consideration of 
how these patients can be supported upon discharge to avoid readmission could be another 
potential use for HGS measurement in hospital. These patients need to be identified in hospital to 
address these important care issues and be provided necessary treatments.   
7.4 Predictive validity of HGS with respect to LOS and QOL 
As mentioned, screening tools need to be simple, objective measures that can be used to 




for predicting important outcomes and need to support clinical decision-making. Of particular 
importance and relevance are LOS (with obvious financial implications for the health care 
system) and QOL (to promote the delivery of patient centered care).   
 Correlations between HGS and LOS were significant and in the anticipated direction, 
confirming that lower HGS values are associated with longer LOS. Yet an association is not 
sufficient to demonstrate the relevance of a new tool in clinical practice. The inclusion of a new 
clinical measure on all patients needs to demonstrate at minimum that it adds value to treatment 
decisions and is associated with patient outcomes, as well as being responsive to treatment. This 
analysis demonstrated that HGS provided additional predictive value for LOS when adjusting for 
other covariates that would be collected in a clinical setting. Based on this analysis, HGS appears 
to be a promising tool for measuring frailty and predicting clinical outcomes such as LOS in this 
setting.  The overall low R2 values of the predictive models may in part be attributed to the 
amount of variance inherent in the outcome (LOS). It is recommended that further predictive 
validity of HGS be assessed for other clinical outcomes in a more representative sample to 
determine its utility while adjusting for other relevant covariates (e.g. disease severity) that likely 
influence these outcomes.  
Correlations between HGS and physical components of QOL were also significant and in 
the anticipated direction, confirming that lower HGS values are associated with poorer physical 
QOL. However, HGS does not appear to be strongly associated with the mental summary scores 
generated by the SF-12, indicating it is not reflective of mental QOL. As with LOS, this analysis 
demonstrated that HGS provided additional predictive value for PCS1/PCS2 when adjusting for 




to be a potential tool for measuring frailty and predicting clinical outcomes such physical QOL 
in this setting.  
If objective tools are to be used in clinical practice, they require a score or cut-point upon 
which decisions are made with respect to treatment options. Development of new cut-points for 
HGS based on this sample was not considered appropriate, as eligible patients included in this 
data collection were not representative of all medical patients (i.e. excluded persons with 
dementia, not living in the community, too unwell to participate).  Thus, this analysis was 
focused on determining if current published cut-points would be appropriate when considering 
the outcome of LOS. The cut-points chosen in this study to identify frailty with HGS have been 
used in the past to determine functional disability and mobility limitations (Alley et al., 2014; 
Giulani et al., 2008; Sallinen et al., 2010) and are below the 50th percentile HGS reference values 
for similar age categories (Stats Canada, 2007 to 2013 Canadian Health Measures Survey 
(reference equations)), indicating that they are likely capturing less well individuals. However, 
these existing HGS and 5m cut-points for frailty do not appear to be useful for predicting LOS, 
as all cut-points produced SE/SP/AUC values <0.70. These results reveal that if further work is 
pursued with HGS cut-points need to be improved and re-assessed to capture and predict clinical 
outcomes such as LOS in an unbiased sample.  
7.5 HGS- a superior single indicator for frailty in acute care  
 Overall, HGS appears to be a more appropriate single indicator for frailty for 
consideration of use in acute care. This tool has shown that it is feasible, and can be completed 
by both male and female medical patients and those who are >65 years. This tool appears to be 
related with nutritional status and perceived functional disability, indicating that it is likely 




important outcomes and clinical decision-making. Lower HGS values were correlated with 
longer LOS and poorer physical QOL. HGS also provided additional predictive value for LOS 
and physical QOL in hospital and 30 days post-discharge when adjusting for other covariates that 
would be collected in a clinical setting, including nutritional status. Consideration for use of this 
tool in acute care should be considered once appropriate cut-points have been determined.  
 
Figure 2: Summary of Findings 
Frailty and malnutrition have specific defining criteria, but both encompass the notion of 
reduced functional capacity- hence the need for functional measures to add to a nutrition/frailty 
assessment toolkit. HGS is the most appropriate functional measure to suggest for use in acute 
care. HGS was feasible across sexes and in those >65 years. HGS added significant predictive 




with nutritional status, food intake, SES (education, living situation) and perceived disability). 
However, SE/SP of HGS cut points were not sufficient to predict LOS, indicating that perhaps 
this tool needs to be used in addition to other existing measures to add predictive value.  
7.6 Next Steps 
 In order to fully develop HGS as an indicator, the validity of cut-points needs to be 
considered. Existing HGS cut-points do not appear to be useful for predicting LOS. If further 
work is pursued with this measure, cut-points need to be improved and re-assessed to capture and 
predict clinical outcomes such as LOS in an unbiased sample. Furthermore, validation testing 
against a criterion such as the CFS or FACT tool needs to be done in the acute care setting 
(Jones, 2004). This should also be done in an unbiased sample, large enough to produce 
generalizable results in a Canadian context. Finally, the clinical utility of the tool needs to be 
explored further. More specifically, the transition from screening to changes in treatment needs 
to be focused on. When suggesting a new screening tool, it is important to consider the benefits, 
risks, and costs associated with the implementation of screening (Silvestre et al., 2011). It is also 
important to consider addressing the time taken to deal with false positives, and ensure that these 
cases are minimized in a fast-paced acute care setting (Phillips & Zechariah, 2017). Although we 
can assume that the utility of this tool would be highest if screening happened at admission (to 
implement greater care strategies during hospitalization), further research needs to be conducted 
on how and when this tool can be used by clinicians, and what treatment strategies can be used to 
mitigate the effects of frailty in hospitalized patients (e.g. addressing barriers to food intake). 
Finally, future work on HGS as a measure to conduct with nutritional screening or malnutrition 
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